Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1050.Time spend outdoors in summer,49262,0.00652761910615874,0.0284767517413387,-0.0492868143068652,0.0623420525191827,0.818694914159141
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1060.Time spent outdoors in winter,45458,0.0413005973944771,0.0326166550818851,-0.0226280465660177,0.105229241354972,0.205439905669223
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X1070.Time spent watching television (TV),50449,-0.051887370723693,0.0283069769776924,-0.10736904559997,0.00359430415258406,0.0668101634081577
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X1080.Time spent using computer,45420,0.0529901239070966,0.0306541213805505,-0.00709195399878228,0.113072201812976,0.0838867908285728
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X1090.Time spent driving,44275,-0.0341011938262521,0.0319887054973646,-0.0967990566010868,0.0285966689485826,0.286418815039985
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1160.Sleep duration,52282,-0.023718267766802,0.0266971526487057,-0.0760446869582653,0.0286081514246612,0.37432272393839
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34629,0.0290460154734639,0.0129921948444641,0.00358131357831431,0.0545107173686134,0.0253950405400984
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34629,-0.0251165849615388,0.0127722585223741,-0.0501502116653921,-8.29582576855718e-05,0.0492670793827576
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34629,-0.00520744980534553,0.0149408646697129,-0.0344915445579828,0.0240766449472918,0.727443460769136
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34629,-0.0197742834951355,0.0155341519114676,-0.0502212212416119,0.010672654251341,0.20306132680868
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34629,-0.0332979273391498,0.0159949349283588,-0.064647999798733,-0.00194785487956665,0.037386174349417
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34629,-0.0260831213624655,0.0307493300524055,-0.0863518082651802,0.0341855655402492,0.396317571203744
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34629,-0.079801064842339,0.0318313080282164,-0.142190428577643,-0.0174117011070348,0.0121907062370572
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34629,-0.0194756736362867,0.0223784530796634,-0.0633374416724269,0.0243860943998534,0.384163056806125
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34629,-0.0260156392160005,0.0165566217732843,-0.0584666178916378,0.00643533945963677,0.11613928261269
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34629,-0.0239187320668751,0.0115886517697599,-0.0466324895356045,-0.00120497459814577,0.0390436210792216
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34629,-0.0138963511545118,0.0164151338202614,-0.0460700134422241,0.0182773111332006,0.397260741192584
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34629,-0.0276281581356623,0.00943142911388597,-0.0461137591988788,-0.00914255707244581,0.00340360827357272
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34629,-0.00323656895992205,0.0121045879121059,-0.0269615612676495,0.0204884233478054,0.789178903112617
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34629,-0.0365360769823126,0.0183722781238989,-0.0725457421051546,-0.000526411859470721,0.0467648376393451
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34629,-0.012086167686267,0.0173528390134827,-0.046097732152693,0.021925396780159,0.486133845073715
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34629,-0.00383151725854299,0.0213937575021857,-0.045763281962827,0.038100247445741,0.85786639428068
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34629,-0.00443681928263181,0.0201780403303684,-0.0439857783301539,0.0351121397648903,0.825966010217334
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34629,-0.0282664938486385,0.0134791715089707,-0.0546856700062211,-0.00184731769105594,0.0360124278449927
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34629,-0.0105395043541632,0.0128265800065383,-0.0356796011669782,0.0146005924586519,0.411270130199769
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34629,-0.0012785602139751,0.0158209000842919,-0.0322875243791872,0.029730403951237,0.935590873445583
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120040.Fatigue severity over the past week,34637,-0.0677042778226875,0.0448478339101043,-0.155606032286492,0.0201974766411169,0.131163527189705
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120041.Waking unrefreshed severity over the past week,34639,-0.0809983107353402,0.0443303286807765,-0.167885754949662,0.00588913347898178,0.0677043495171816
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120042.Cognitive symptoms severity over the past week,34637,-0.0137331231338264,0.0483936248951452,-0.108584627928311,0.0811183816606583,0.776584747404822
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120098.Mobility problems today,34642,-0.0598098990686976,0.0543102718669486,-0.166258031927917,0.0466382337905216,0.270806750883991
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120099.Self-care problems today,34642,-0.213562123774336,0.0844751999312157,-0.379133515639519,-0.047990731909153,0.0114821849759577
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120100.Problems doing usual activities,34642,-0.0756841453208617,0.0514692963165708,-0.17656396610134,0.025195675459617,0.141463224900536
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120101.Pain or discomfort today,34642,-0.0478470034886414,0.0449610667826001,-0.135970694382538,0.0402766874052549,0.287267624817165
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120102.Anxiety or depression today,34642,0.00804255538044514,0.0530918318191,-0.0960174349849909,0.112102545745881,0.879596880172333
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120103.Scale to indicate how health is today,34607,0.0068905462219903,0.00408030972453343,-0.00110686083809523,0.0148879532820758,0.0912999694908444
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34626,-0.0746166573527567,0.0530904492976872,-0.178673937976224,0.0294406232707102,0.159912532264581
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34611,-0.0668445248237926,0.0542243782355482,-0.173124306165467,0.0394352565178819,0.217699985700473
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34631,-0.0644380729466656,0.0441731798507861,-0.151017505454206,0.022141359560875,0.144660308474634
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34631,-0.115384953491315,0.0452184760335079,-0.20401316651699,-0.0267567404656393,0.010732910790614
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34628,-0.0196928132496832,0.0553224758053912,-0.12812486582825,0.0887392393288835,0.721874453166239
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120109.Feeling bad about self over the last two weeks,34601,0.0060807615814202,0.0561726387539399,-0.104017610376302,0.116179133539142,0.913798369037022
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120110.Trouble concentrating over the last two weeks,34633,-0.0328768924652941,0.0565894196188646,-0.143792154918269,0.0780383699876804,0.561271192722288
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34617,-0.185688594001187,0.0843424995143882,-0.350999893049388,-0.0203772949529862,0.0277146101772799
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34566,-0.0506896945532856,0.1097565238063,-0.265812481213634,0.164433092107063,0.644207137902629
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",31572,-0.0975011492652197,0.0588619717125808,-0.212870613821878,0.0178683152914386,0.0976740397783216
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49177,-0.0449913370647531,0.063826965779588,-0.170092189992746,0.0801095158632394,0.480881793560458
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,47869,-0.0456075453533763,0.0387763871053977,-0.121609264079956,0.0303941733732031,0.239539414665856
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1289.Cooked vegetable intake,51240,-0.115947892663905,0.0274800010419605,-0.169808694706147,-0.0620870906216622,2.45789832148178e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50692,-0.0501144198368658,0.0293813608402574,-0.10770188708377,0.00747304741003878,0.0880841933647406
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1309.Fresh fruit intake,51223,0.0130199160857225,0.0292744165870246,-0.0443579404248457,0.0703977725962907,0.656501003762659
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1319.Dried fruit intake,49657,0.0102868296034409,0.0308399659075582,-0.050159503575373,0.0707331627822549,0.738717974245146
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X134.Number of self-reported cancers,52513,-0.0141777309583297,0.060937535709919,-0.133615300949771,0.105259839033111,0.816027044474933
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X135.Number of self-reported non-cancer illnesses,52513,-0.209395075727335,0.0268558061479797,-0.262032455777375,-0.156757695677295,6.5533008973073e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X136.Number of operations, self-reported",52513,0.0761494673522695,0.0267675318070061,0.0236851050105375,0.128613829694001,0.0044464589539731
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X137.Number of treatments or medications taken,52513,-0.319069736888894,0.0268543581881275,-0.371704278937624,-0.266435194840164,1.76098929797992e-32
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1438.Bread intake,51628,0.00468988867084368,0.00259031266782062,-0.000387124158084731,0.0097669014997721,0.0702214569752725
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1458.Cereal intake,50857,-0.0116763062546188,0.0276781481369626,-0.0659254766030654,0.0425728640938278,0.673130496407901
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1488.Tea intake,51410,-0.00715170664875274,0.00245181611012651,-0.0119572662246007,-0.00234614707290478,0.00353812447422179
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1498.Coffee intake,50137,-0.220647540522323,0.0279680596997408,-0.275464937533815,-0.165830143510831,3.1572686268301e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1528.Water intake,50469,0.0515515260758777,0.0283229809103904,-0.00396151650848744,0.107064568660243,0.0687503381793328
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1568.Average weekly red wine intake,43304,0.0100315445612942,0.0323940061310644,-0.053460707455592,0.0735237965781804,0.756813061286139
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,43297,0.0776466386628173,0.0331962792209788,0.0125819313896988,0.142711345935936,0.0193446655070219
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1588.Average weekly beer plus cider intake,43350,0.0769749321322205,0.0363175770779873,0.00579248105936547,0.148157383205076,0.0340612416535421
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1598.Average weekly spirits intake,43271,-0.0810496746970044,0.0363762198698452,-0.152347065641901,-0.0097522837521079,0.0258855909849036
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1608.Average weekly fortified wine intake,43339,0.0661316874094876,0.0663394828365914,-0.0638936989502316,0.196157073769207,0.318841117286678
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1737.Childhood sunburn occasions,45915,0.0309608576319276,0.0321218417108124,-0.0319979521212646,0.0939196673851198,0.335128260900269
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1807.Father's age at death,40947,0.00802843948573362,0.00346616138731665,0.00123476316659299,0.0148221158048743,0.0205572892162035
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1845.Mother's age,40209,0.00299051839529569,0.00525079641355907,-0.00730104257528009,0.0132820793658715,0.569000167432336
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1873.Number of full brothers,52004,0.0333807666799156,0.0267780481534127,-0.0191042077007733,0.0858657410606045,0.212564826615684
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1883.Number of full sisters,52006,-0.0401909738187902,0.0267672006664441,-0.0926546871250206,0.0122727394874403,0.133237292385406
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20015.Sitting height,52278,0.0250011260565848,0.00328039629488179,0.0185715493186165,0.0314307027945531,2.58803103600996e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20016.Fluid intelligence score,32885,0.135881992090788,0.0445692654473945,0.048526231813895,0.223237752367681,0.00230437203975311
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20018.Prospective memory result,33217,-0.204511529509465,0.0630602364965836,-0.328109593042769,-0.0809134659761616,0.00118645564316909
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),32795,-0.00709612597342196,0.00463692156448646,-0.0161844922398154,0.00199224029297151,0.125964822701843
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),32788,-0.0111142933420661,0.00460078531278428,-0.0201318325551233,-0.00209675412900892,0.0157232877618394
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20023.Mean time to correctly identify matches,52195,-0.00356026641632937,0.00260579555315533,-0.00866762570051382,0.00154709286785507,0.171859522108444
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#1.Illnesses of father_Heart disease,49205,-0.0111365665604645,0.00562705205539361,-0.022165588589036,-0.000107544531893001,0.0478141961915423
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48768,0.00541248950348383,0.0127825207850812,-0.0196412512352752,0.0304662302422429,0.671985974108954
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48731,0.00228493324247614,0.0172581462681339,-0.0315410334430663,0.0361108999280186,0.894671062836504
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#12.Illnesses of father_Severe depression,48763,0.0098497276688628,0.0131846657127406,-0.0159922171281089,0.0356916724658345,0.455034795327399
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48766,0.00321654628726463,0.00958929356152756,-0.0155784690933294,0.0220115616678586,0.737302814942745
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#2.Illnesses of father_Stroke,48930,-0.00335874463794688,0.00740378533701953,-0.0178701638985052,0.0111526746226114,0.650082992836487
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48867,-0.00187154557934828,0.00963291630223193,-0.0207520615317229,0.0170089703730263,0.845953134964414
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48769,0.003864828177803,0.01159888483207,-0.0188689860930542,0.0265986424486602,0.738980932739254
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48896,-0.00599351761175619,0.00916355056112019,-0.0239540767115518,0.0119670414880394,0.513078755273978
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#8.Illnesses of father_High blood pressure,49055,-0.0012385135026416,0.00581318892628182,-0.012632363798154,0.0101553367928708,0.831287862172471
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#9.Illnesses of father_Diabetes,48899,-0.0233304202861101,0.00793908473015168,-0.0388910263572074,-0.00776981421501286,0.0032991515195588
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#1.Illnesses of mother_Heart disease,50284,-0.00433434970830575,0.00676205454836215,-0.0175879766230956,0.00891927720648406,0.521540469015048
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,50151,-0.00110795729625739,0.0109378640833881,-0.022546170899698,0.0203302563071832,0.919316596517526
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,50095,0.0348485224455095,0.0229879371839975,-0.0102078344351257,0.0799048793261447,0.129544494206646
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#12.Illnesses of mother_Severe depression,50143,-0.017738045741026,0.0098544952890541,-0.037052856507572,0.00157676502552008,0.0718728345064489
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#2.Illnesses of mother_Stroke,50230,-0.000645757754451333,0.00800139300620435,-0.0163284880466119,0.0150369725377092,0.935676642867213
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,50150,0.0071201207263348,0.0130526125715143,-0.0184629999138332,0.0327032413665028,0.585418492757589
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,50126,0.00876772164182664,0.012429574663675,-0.0155942446989763,0.0331296879826296,0.480572621083969
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,50160,0.0119523469268113,0.00937757966451832,-0.00642770921564464,0.0303324030692672,0.20247405614628
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,50164,0.0134046976929243,0.011028914334563,-0.00821197440281928,0.0350213697886679,0.224219111778567
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,50385,0.00539596548105908,0.00531453512312673,-0.00502052336026931,0.0158124543223875,0.309961527444589
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#9.Illnesses of mother_Diabetes,50218,-0.0111921579766795,0.00823671536385523,-0.0273361200898358,0.00495180413647674,0.174217400761118
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,47381,-0.0309354852862986,0.0108587981523542,-0.0522187296649127,-0.0096522409076844,0.00439105773201585
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,47264,-0.00488668342203438,0.0604526200297627,-0.123373818680369,0.113600451836301,0.93557391852506
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,47263,0.0456605731898547,0.0522675099735238,-0.056783746358252,0.148104892737961,0.382348461965402
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,47352,-0.00701070511049311,0.00994337083658695,-0.0264997119502035,0.0124783017292173,0.480777881156478
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,47269,0.0565335513084921,0.0336251178161867,-0.00937167961123392,0.122438782228218,0.0927200720580293
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#2.Illnesses of siblings_Stroke,47282,-0.0117036316169061,0.018754517847335,-0.0484624865976827,0.0250552233638706,0.532605212337881
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,47271,0.0164041829255508,0.0252001450317524,-0.0329881013366839,0.0657964671877855,0.515081348016406
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,47279,-0.0146367647019792,0.0224455658717999,-0.058630073810707,0.0293565444067486,0.514342742151548
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,47284,0.0386989087828403,0.0150902676698707,0.00912198414989381,0.0682758334157868,0.0103387962350004
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,47288,0.0101679312197284,0.0197621239633915,-0.0285658317485189,0.0489016941879758,0.606896050915798
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,47473,0.0042613687322437,0.00698860331277041,-0.0094362937607863,0.0179590312252737,0.54202686143383
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,47364,-0.0230604875298105,0.0102217771794713,-0.0430951708015742,-0.00302580425804677,0.0240788134521208
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20127.Neuroticism score,46868,-0.0198716539118539,0.027805899923696,-0.074371217762298,0.0346279099385902,0.47482887095604
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,32885,0.0658517806571097,0.0453711518981845,-0.0230756770633319,0.154779238377551,0.146702753319493
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X20161.Pack years of smoking,31780,-0.036781099881507,0.00537831477821712,-0.0473225968468126,-0.0262396029162015,8.58079481110575e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,31780,-0.0342149134872601,0.00502863317499931,-0.0440710345102588,-0.0243587924642615,1.09147569294689e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20191.Fluid intelligence score,31485,0.141048638864743,0.0490208625858651,0.0449677481964479,0.237129529533039,0.00402185670118722
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,31485,0.0958790261154103,0.0501067268987538,-0.00233015860614709,0.194088210836968,0.0557220372297975
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20240.Maximum digits remembered correctly,30830,0.079703714776046,0.0515392012305491,-0.0213131196358301,0.180720549187922,0.122037084752127
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20255.Spirometry QC measure,45295,-0.0384142703226079,0.0358762846713329,-0.10873178827842,0.0319032476332046,0.284297187414758
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X20261.avMSE,30018,-0.0102646390354373,0.00579445264519238,-0.0216217662200144,0.00109248814913973,0.0765337455431191
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X20262.Myopia diagnosis,30018,0.0683293914285479,0.0655719249821873,-0.0601915815365392,0.196850364393635,0.297428231824352
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X20280.Glucose-lactate,40018,-0.00848783376677714,0.00337867828723387,-0.0151100432097555,-0.00186562432379875,0.0120085946468291
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X20281.Spectrometer-corrected alanine,40054,0.013563250839268,0.00333180214920074,0.00703291862683456,0.0200935830517015,4.70653266875848e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,32774,-0.00631217914386173,0.0158624489298783,-0.0374025790464233,0.0247782207586998,0.690689695698587
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,32771,0.00329515432223475,0.0318118212149984,-0.0590560152591621,0.0656463239036316,0.917502848466695
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),32769,-0.0393986427435746,0.0352588247873707,-0.108505939326821,0.029708653839672,0.263848232108644
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),32769,-0.00348737535369097,0.0153101202875621,-0.0334952111173128,0.0265204604099308,0.819820666929722
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),32769,-0.00475253602115903,0.0246852282458429,-0.053135583383011,0.043630511340693,0.847334980143889
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,32776,-0.00656613145649015,0.0316589929794863,-0.0686177576962834,0.0554854947833031,0.835700830177844
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,32776,-0.0123257953117075,0.0209356981863515,-0.0533597637569565,0.0287081731335414,0.55604701421844
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,32776,0.00313238807783209,0.0228749579662696,-0.0417025295360564,0.0479673056917206,0.891085067975215
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,32776,0.030016076109314,0.0356205508351086,-0.039800203527499,0.0998323557461269,0.399440242364027
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,32776,0.0562448693697723,0.04128149323141,-0.0246668573637912,0.137156596103336,0.173083459804535
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,32776,-0.0346765302947445,0.0234644154043,-0.0806667844871724,0.0113137238976835,0.139487316210066
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,32776,0.0756163807708921,0.0403067248097359,-0.00338479985619018,0.154617561397974,0.060684636392185
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,32776,-0.00416417238543804,0.0306288194748517,-0.0641966585561473,0.0558683137852713,0.891859118528247
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),32779,-0.0754771540383588,0.0414412598205765,-0.156702023286689,0.00574771520997117,0.0685940631484883
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),32779,-0.0251305254886618,0.02037370192809,-0.0650629812677182,0.0148019302903946,0.217429758372852
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),32779,0.0222441578981659,0.0282033866916797,-0.0330344800175264,0.0775227958138582,0.430305287877934
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,32779,0.0376360818086832,0.0464111759536822,-0.053329823060534,0.1286019866779,0.417429156157952
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20600.Liking for adding salt to foods,35529,0.0794297447195563,0.0395664314945959,0.00187953899014837,0.156979950448964,0.0447191226845386
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20601.Liking for aniseed,35529,0.00712332385257173,0.0392550207367179,-0.0698165167913953,0.0840631644965388,0.85600752631293
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20602.Liking for apple juice,35529,-0.0306476044472344,0.0396467800634994,-0.108355293371693,0.0470600844772244,0.439528445333539
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20603.Liking for apples,35529,-0.0346434165739414,0.0403404134529251,-0.113710626941675,0.0444237937937918,0.390481249307063
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20604.Liking for asparagus,35529,-0.0136508525218549,0.0400257777553869,-0.0921013769224132,0.0647996718787035,0.733070938584261
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20605.Liking for aubergine,35529,-0.0265444261510083,0.0394448183436764,-0.103856270104614,0.0507674178025976,0.500991862663434
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20606.Liking for avocados,35529,-0.0070318943152693,0.0401087478692553,-0.0856450401390098,0.0715812515084712,0.860830680670933
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20607.Liking for bacon,35529,-0.0399483988528934,0.0399562473098089,-0.118262643580119,0.0383658458743321,0.317426323700959
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20608.Liking for baked or steamed fish,35529,-0.206478985887944,0.0401856299087633,-0.28524282050912,-0.127715151266768,2.81971632197131e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20609.Liking for bananas,35529,-0.0688333497020023,0.0409548079369262,-0.149104773258378,0.011438073854373,0.0928451191289094
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35529,-0.10422877454992,0.0397774988019357,-0.182192672201714,-0.0262648768981262,0.00879676647322478
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20611.Liking for beef steak,35529,-0.0855523169917504,0.0399050283671343,-0.163766172591334,-0.00733846139216709,0.032061665417181
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20612.Liking for beetroot,35529,-0.0562619160890069,0.0401575173107628,-0.134970650018102,0.0224468178400881,0.161231495094569
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20613.Liking for bell pepper,35529,-0.0744011746648358,0.0398304890116754,-0.15246893312772,0.00366658379804803,0.0617947600105794
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20614.Liking for bicycling,35529,0.142879263844836,0.0393775019095078,0.0656993601022008,0.220059167587471,0.00028634749146726
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20615.Liking for biscuits,35529,0.0639690437080373,0.0396120542437858,-0.013670582609783,0.141608670025858,0.106361939170101
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20616.Liking for bitter foods,35529,-0.0319188485900776,0.0394323947367156,-0.10920634227404,0.045368645093885,0.418268543469736
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20617.Liking for bitter or ale,35529,0.079453361874027,0.0403115532386542,0.000442717526264805,0.158464006221789,0.0487495024671523
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20618.Liking for black olives,35529,0.018228389986718,0.039646829975725,-0.0594793967657029,0.0959361767391389,0.645690489126226
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20619.Liking for black pepper,35529,-0.0196576659890228,0.0398610041725923,-0.0977852341673037,0.0584699021892582,0.621912137481724
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20620.Liking for blue cheese,35529,-0.0596718057501305,0.039812290409859,-0.137703894953454,0.0183602834531931,0.133945134335163
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20621.Liking for bolognese sauce,35529,-0.0475293413476484,0.0402001638731919,-0.126321662539105,0.0312629798438078,0.237104010689584
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20622.Liking for broad beans,35529,-0.046825909657297,0.0394716943711833,-0.124190430624816,0.0305386113102222,0.235521631369516
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20623.Liking for broccoli,35529,-0.00570349976589352,0.0408041083631923,-0.0856795521577505,0.0742725526259635,0.888838137408611
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20624.Liking for brown rice,35529,-0.0420325693151029,0.0394716753249294,-0.119397052951964,0.0353319143217586,0.286952611914106
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20625.Liking for brussel sprouts,35529,-0.0844175102699536,0.0399064669956376,-0.162634185581403,-0.00620083495850386,0.034418362307429
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20626.Liking for burgers (meat),35529,-0.0131424685940166,0.0393838416796619,-0.090334798286154,0.0640498610981208,0.738610405418162
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20627.Liking for burn of spicy foods,35529,-0.0492922777558799,0.0393470910859266,-0.126412576284296,0.0278280207725364,0.21031988931559
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20628.Liking for butter on bread,35529,-0.0138132851037171,0.0399435123083568,-0.0921025692280964,0.0644759990206622,0.72948386244126
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20629.Liking for butternut squash,35529,0.0848606757139178,0.0395153558957337,0.0074105781582797,0.162310773269556,0.0317711308062766
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20630.Liking for cabbage,35529,-0.0780377884740412,0.0399075672239434,-0.15625662023297,0.000181043284887897,0.0505522459100484
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20631.Liking for cake,35529,0.0142023290789884,0.0396677145723953,-0.0635463914829063,0.0919510496408832,0.720325509653387
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20632.Liking for cake icing,35529,0.00720356098986481,0.0390240919594363,-0.0692836592506304,0.08369078123036,0.853551752740398
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20633.Liking for capers,35529,-0.0305791013083515,0.0394461024774249,-0.107893462164104,0.0467352595474013,0.438229979904369
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20634.Liking for cauliflower,35529,-0.107591948153405,0.0401239211490598,-0.186234833605562,-0.0289490627012476,0.00733979923152461
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20635.Liking for cereal or granola bar,35529,-0.0176449556934123,0.0392462270410553,-0.0945675606938808,0.0592776493070561,0.653009964607021
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20636.Liking for cheesecake,35529,0.00925936473230045,0.0394189972845123,-0.0680018699453436,0.0865205994099445,0.814293580054875
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20637.Liking for cherries,35529,-0.0710277908199272,0.0410434535600855,-0.151472959797695,0.00941737815784033,0.083558329715579
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20638.Liking for chicken,35529,-0.112857294863353,0.0416653207568193,-0.194521323546718,-0.0311932661799867,0.00676536126184942
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20639.Liking for chilli pepper,35529,-0.00614738361597289,0.039693979455226,-0.0839475833482158,0.07165281611627,0.87692694181841
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20640.Liking for chips or french fries,35529,0.0260393422956702,0.0397833366852522,-0.051935997607424,0.104014682198764,0.512784045388994
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20641.Liking for cigarette smoking,35529,-0.0894340231398105,0.0616971912763423,-0.210360518041441,0.0314924717618205,0.147207055036439
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20642.Liking for cod,35529,-0.168428175138022,0.0404219745077921,-0.247655245173295,-0.0892011051027496,3.11204221618362e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20643.Liking for coffee with sugar,35529,0.00303109487090961,0.0431447085357585,-0.081532533859177,0.0875947236009962,0.943992579245436
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20644.Liking for coffee without sugar,35529,-0.116554841446277,0.0403338964592414,-0.19560927850639,-0.0375004043861636,0.00386260223547945
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20645.Liking for coriander,35529,-0.045336425531285,0.0393964139896233,-0.122553396950947,0.0318805458883767,0.249848231024892
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20646.Liking for corn flakes,35529,-0.0115642460201723,0.0391969212288234,-0.0883902116286662,0.0652617195883215,0.767976637166883
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20647.Liking for cream,35529,0.0348256066252137,0.0391714609926578,-0.0419504569203955,0.111601670170823,0.373991541921621
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20648.Liking for croissant,35529,0.0618140139238054,0.0395451943301893,-0.0156945669633656,0.139322594810976,0.118050738897389
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20649.Liking for cucumber,35529,-0.0848523214245989,0.0396932721641014,-0.162651134866238,-0.0070535079829602,0.0325618059707209
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20650.Liking for curry,35529,-0.090221641316456,0.0400827295895258,-0.168783791311927,-0.0116594913209854,0.0244113301635226
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20651.Liking for dairy products,35529,-0.0643895012341675,0.0399178297544811,-0.142628447552951,0.0138494450846156,0.106760457220608
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20652.Liking for dark chocolate,35529,-0.0929623542588001,0.0394640820444858,-0.170311955065992,-0.015612753451608,0.0185083228009516
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20653.Liking for diet fizzy drinks,35529,-0.0309116538942031,0.0404435644343816,-0.110181040185591,0.0483577323971848,0.444694559487661
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20654.Liking for dried fruit,35529,-0.0355056090558329,0.039577530656992,-0.113077569143537,0.0420663510318713,0.369675907101829
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20655.Liking for eggs,35529,-0.142792891093833,0.0406250531213919,-0.222417995211761,-0.063167786975905,0.000441593189488302
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20656.Liking for exercising alone,35529,0.12663398479591,0.0394159268064329,0.0493787682553019,0.203889201336519,0.00131822502814607
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20657.Liking for exercising with others,35529,0.140631955142442,0.0393134931520117,0.0635775085644994,0.217686401720385,0.000348710916022748
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20658.Liking for extra virgin olive oil,35529,-0.0168732423461557,0.040137889340094,-0.09554350545274,0.0617970207604286,0.674214232217453
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20659.Liking for fatty foods,35529,0.0930090795169765,0.0393140811179117,0.0159534805258695,0.170064678508083,0.0180076380021478
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20660.Liking for fresh tomatoes,35529,-0.0888972044969361,0.0421265131858536,-0.171465170341209,-0.00632923865266306,0.0348586219456708
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20661.Liking for fried chicken,35529,-0.023475791865791,0.0393400428119573,-0.100582275777227,0.0536306920456454,0.550692318248026
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20662.Liking for fried or battered fish,35529,-0.0810043719518193,0.039816194989457,-0.159044114131155,-0.00296462977248362,0.0419280320473435
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20663.Liking for fruit,35529,-0.0977553601762148,0.043346326760093,-0.182714160625997,-0.0127965597264326,0.024138194440314
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20664.Liking for garlic,35529,-0.0424433983792967,0.0401760239959796,-0.121188405411417,0.0363016086528233,0.29079095003499
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20665.Liking for gherkins,35529,-0.0498645253602693,0.0392399452155293,-0.126774817982707,0.0270457672621681,0.203839644234481
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20666.Liking for globe artichoke,35529,-0.0102828119873447,0.0396533291914537,-0.0880033372025938,0.0674377132279045,0.795394665448911
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20667.Liking for goat's cheese,35529,-0.0234346411787827,0.0393098002792379,-0.100481849726089,0.0536125673685236,0.551084833995917
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20668.Liking for going to a cafe,35529,-0.0725244048525163,0.039956236912687,-0.150838629201383,0.00578981949635031,0.0695348415978291
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20669.Liking for going to the gym,35529,0.112402792913301,0.0393173584654836,0.0353407703209528,0.189464815505649,0.00425921327771368
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20670.Liking for going to the pub,35529,0.0503033760703234,0.039519084068133,-0.0271540287032172,0.127760780843864,0.203083093376973
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20671.Liking for grapefruit,35529,-0.0114512252104442,0.0394713957739588,-0.0888151609274034,0.065912710506515,0.77173378359058
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20672.Liking for green olives,35529,-0.00555768062278039,0.0395217652652101,-0.0830203405425923,0.0719049792970315,0.888169978108671
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20673.Liking for haddock,35529,-0.175522023260005,0.0403793255874479,-0.254665501411403,-0.096378545108607,1.3929064273891e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20674.Liking for ham,35529,-0.0296346486809071,0.0395517641540216,-0.107156106422789,0.0478868090609751,0.453714196852183
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20675.Liking for hard cheese,35529,-0.0472797767546955,0.0404701880393346,-0.126601345311791,0.0320417918024003,0.242725044735018
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20676.Liking for herring,35529,-0.0635629900808997,0.0393348884457408,-0.140659371434552,0.0135333912727523,0.106133403363569
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20677.Liking for honey,35529,-0.0473579901562771,0.0395359920797877,-0.124848534632661,0.0301325543201068,0.231001715962266
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20678.Liking for horseradish or wasabi,35529,-0.0123693599487763,0.0393692552721034,-0.089533100282099,0.0647943803845464,0.753383638518374
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20679.Liking for ice cream,35529,0.0166432020165634,0.0396992665612242,-0.0611673604434361,0.0944537644765628,0.675054327153905
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20680.Liking for jam,35529,0.00400031163542198,0.039633598632206,-0.0736815416837018,0.0816821649545458,0.919605910319885
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20681.Liking for kiwi fruit,35529,0.00769684957792061,0.0398333160251576,-0.0703764498313883,0.0857701489872296,0.846785003661204
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20682.Liking for lager,35529,0.0482358483405322,0.040062580548749,-0.0302868095350158,0.12675850621608,0.228609182655673
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20683.Liking for lamb,35529,-0.0400769322309694,0.0398574763972831,-0.118197585969644,0.0380437215077054,0.314674120636618
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20684.Liking for lemons,35529,-0.0228789427930802,0.039701233290751,-0.100693360042952,0.0549354744567919,0.564438490867629
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20685.Liking for lentils or beans,35529,-0.0585846122797384,0.0401068016061811,-0.137193943427853,0.0200247188683765,0.144120577190606
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20686.Liking for liver,35529,-0.088136906443509,0.0397812178387317,-0.166108093407423,-0.010165719479595,0.026742219326896
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20687.Liking for mackerel,35529,-0.0895010672649956,0.0395601362616964,-0.167038934337921,-0.0119632001920706,0.0236906877913643
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20688.Liking for marzipan,35529,-0.00698013937688938,0.0390686421298088,-0.0835546779513147,0.069594399197536,0.858205054219347
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20689.Liking for mayonnaise,35529,-0.0343429744579277,0.0395973457906696,-0.11195377220764,0.0432678232917846,0.385792787108634
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20690.Liking for melon,35529,-0.10396198908824,0.0407104276213499,-0.183754427226086,-0.0241695509503943,0.0106712857697461
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20691.Liking for milk chocolate,35529,0.0670238711628382,0.0397446748241049,-0.0108756914924074,0.144923433818084,0.0917530333605569
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20692.Liking for mushrooms,35529,-0.0528946442225973,0.0406334514858657,-0.132536209134894,0.0267469206896995,0.193027167786995
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20694.Liking for orange juice,35529,-0.032014923254146,0.0393921789919704,-0.109223594078408,0.045193747570116,0.416393581063457
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20695.Liking for oranges,35529,-0.0599806831710072,0.0401006935855125,-0.138578042598612,0.0186166762565973,0.134745419682436
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20696.Liking for pasta,35529,-0.0158264034491213,0.0399766343548688,-0.0941806067846642,0.0625277998864216,0.692192431514505
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20697.Liking for pears,35529,0.0232651497378815,0.0402811820602862,-0.0556859671002794,0.102216266576042,0.563566499870543
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20698.Liking for pizza,35529,0.0227640161971482,0.0396082106882376,-0.0548680767517974,0.100396109146094,0.565485186453749
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20699.Liking for plain yogurt,35529,-0.0289564924758157,0.0396868738334364,-0.106742765189351,0.0488297802377197,0.465634753199201
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20700.Liking for plums,35529,-0.0872847751445542,0.0402193601962443,-0.166114721129193,-0.00845482915991543,0.0300104626040612
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20701.Liking for pollock,35529,-0.0867118353081044,0.039437786485935,-0.164009896820537,-0.00941377379567185,0.0279188790586395
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20702.Liking for pork chop,35529,-0.0480309259218039,0.0395905590677862,-0.125628421694665,0.029566569851057,0.225081226281848
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20703.Liking for porridge,35529,-0.0269277889131261,0.0400419752916569,-0.105410060484774,0.0515544826585215,0.501285750728905
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20704.Liking for potato crisps,35529,0.0254077788989918,0.0397381645058351,-0.0524790235324451,0.103294581330429,0.522588460013888
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20705.Liking for potatoes,35529,-0.0168218364387139,0.0400272969670982,-0.0952753384942264,0.0616316656167985,0.674303916739785
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20706.Liking for prawns,35529,-0.122979325702344,0.0401658514775325,-0.201704394598308,-0.0442542568063807,0.00220520040193585
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20707.Liking for raw carrots,35529,-0.00894666715411244,0.0400633542005419,-0.0874708413871745,0.0695775070789496,0.823295835035141
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20708.Liking for red meat,35529,-0.0621774250193024,0.0397255058529202,-0.140039416491026,0.0156845664524211,0.117568686282773
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20709.Liking for red wine,35529,0.0304014909738808,0.0397796681349166,-0.0475666585705558,0.108369640518317,0.444735543826888
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35529,0.0764883119426684,0.0405390701108317,-0.00296826547456183,0.155944889359899,0.0592147270202725
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20711.Liking for roast chicken,35529,-0.118952186727263,0.0415329202512286,-0.200356710419671,-0.037547663034855,0.00419014061382764
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20712.Liking for salad dressing,35529,-0.0221155864416015,0.0393731807509607,-0.0992870207134844,0.0550558478302815,0.574336927449194
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20713.Liking for salad leaves,35529,-0.0511862662287613,0.0403339590372979,-0.130240825941865,0.0278682934843426,0.204444535478328
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20714.Liking for salami,35529,0.037216178286104,0.0394548104987662,-0.0401152502914778,0.114547606863686,0.345567036553891
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20715.Liking for salmon,35529,-0.152391026413292,0.0410457798309901,-0.232840754882033,-0.0719412979445518,0.000206008112240694
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20716.Liking for salty foods,35529,0.0657393687371872,0.0392291273021299,-0.0111497207749874,0.142628458249362,0.0938081953711506
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20717.Liking for salty pretzels,35529,0.0252413575687721,0.0395272668910626,-0.0522320855377106,0.102714800675255,0.523108153797019
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20718.Liking for sardines,35529,-0.118466372871328,0.039368029869863,-0.19562771141626,-0.0413050343263969,0.00262494173601604
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20719.Liking for sausages (meat),35529,-0.0162904721499613,0.0395721163898091,-0.0938518202739871,0.0612708759740644,0.680592236458876
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20720.Liking for savoury biscuits,35529,-0.0043638472868157,0.0399407330209387,-0.0826476840078556,0.0739199894342242,0.912999685210115
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35529,-0.0642511737244307,0.039492038304054,-0.141655568800376,0.013153221351515,0.10377687909517
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20722.Liking for skimmed milk,35529,-0.109660913577932,0.0395457182082461,-0.187170521266094,-0.0321513058897692,0.00556275814911335
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20723.Liking for smoked fish,35529,-0.124060501249679,0.0396931734835381,-0.201859121277414,-0.0462618812219446,0.00177946695714476
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20724.Liking for soft cheese,35529,-0.0193628730800944,0.0395434764687526,-0.0968680869588495,0.0581423407986607,0.624383465526212
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20725.Liking for soy sauce,35529,-0.0289872017346196,0.0396344501511448,-0.106670724030863,0.0486963205616243,0.464571672810561
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20726.Liking for soya milk,35529,-0.00706703048170083,0.0395896389921978,-0.0846627229064084,0.0705286619430068,0.858327870099775
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20727.Liking for spicy foods,35529,-0.0588833519630937,0.0396458826142057,-0.136589281886937,0.0188225779607495,0.137509288907424
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20728.Liking for spinach,35529,-0.0653016754832018,0.0398933529405245,-0.14349264724663,0.0128892962802263,0.101677063597119
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20729.Liking for spirits,35529,-0.00205475911491228,0.0396440810882938,-0.0797571580479682,0.0756476398181436,0.95866491050412
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20730.Liking for strawberries,35529,-0.0722764828967453,0.0431192516350186,-0.156790216101382,0.0122372503078911,0.0937258637340156
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35529,0.00217952097846934,0.0402572303749476,-0.0767246505564279,0.0810836925133666,0.956824659438185
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20732.Liking for sweet foods,35529,0.0764491919799313,0.0393003701844102,-0.000579533581512665,0.153477917541375,0.0517684506562703
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20733.Liking for taking the stairs,35529,0.0267615450300152,0.0405418547279373,-0.0527004902367419,0.106223580296772,0.509204806947197
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20734.Liking for tea with sugar,35529,0.0425496583741422,0.0474196943449921,-0.0503929425420424,0.135492259290327,0.369577758049658
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20735.Liking for tea without sugar,35529,-0.00106723275681296,0.0412497160074213,-0.0819166761313587,0.0797822106177328,0.97935948734079
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20736.Liking for tomato ketchup,35529,-0.0294693236891262,0.0393964240255439,-0.106686314779192,0.0477476674009398,0.454463018191177
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20737.Liking for tinned tuna,35529,-0.090449085686254,0.0396907398843721,-0.168242935859623,-0.0126552355128848,0.0226942148282306
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20738.Liking for turnip (white),35529,-0.0440807675483787,0.0393624700805242,-0.121231208906206,0.0330696738094488,0.262793116807693
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20739.Liking for vegetables,35529,-0.079272806689118,0.0434487243418187,-0.164432306399083,0.00588669302084666,0.0680999761670313
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20740.Liking for vinegar,35529,-0.0499906868350284,0.0395109254216166,-0.127432100661397,0.0274507269913401,0.205811647391429
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20741.Liking for watching television,35529,-0.0100416707071708,0.0395546778964277,-0.0875688393841691,0.0674854979698275,0.79960194057066
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20742.Liking for whisky,35529,0.047325387800581,0.0410975513273464,-0.0332258128010179,0.12787658840218,0.249534625409434
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20743.Liking for white bread,35529,-0.0446837546849996,0.0394469153994997,-0.121999708868019,0.0326321994980197,0.257339764018241
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20744.Liking for white rice,35529,0.00563190299460988,0.0395973958289587,-0.0719789928301491,0.0832427988193689,0.886901483914982
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20745.Liking for white wine,35529,0.114162398535276,0.0394210122426007,0.0368972145397783,0.191427582530773,0.00378680797385885
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35529,0.00169406942845338,0.0399153447766926,-0.076540006333864,0.0799281451907708,0.966147426231013
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20747.Liking for whole milk,35529,0.0615220842560465,0.0394169840906644,-0.0157352045616558,0.138779373073749,0.118597754374505
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20748.Liking for wholemeal bread,35529,-0.058252732653432,0.0412366529163711,-0.139076572369519,0.0225711070626553,0.157786955822913
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20749.Liking for working up a sweat,35529,0.160777157154337,0.0394473722510569,0.0834603075422651,0.238094006766408,4.6172748617328e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X21001.Body mass index (BMI),52380,-0.0287483589342202,0.0103518842387554,-0.0490380520421808,-0.00845866582625955,0.00548797938117587
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X21002.Weight,52401,0.0332002183101028,0.00602598063582704,0.0213892962638818,0.0450111403563238,3.62932096052545e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X21021.Pulse wave Arterial Stiffness index,33134,-0.00130616923890134,0.00482595576531246,-0.0107650425389137,0.00815270406111108,0.786662384300704
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34882,-0.0838401730818481,0.0425773887431861,-0.167291855018493,-0.000388491145203299,0.0489638348195835
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34882,0.0219999374987646,0.0441460150900968,-0.0645262520778251,0.108526127075354,0.618250975871109
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34882,-0.0327059448933922,0.043742901070587,-0.118442030991743,0.0530301412049583,0.45466566882454
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21040.Satisfaction with bowel habits,34852,-0.0948042892516966,0.0407284188986913,-0.174631990293132,-0.0149765882102616,0.0199451345469104
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34849,-0.0649851640356532,0.0428432385745148,-0.148957911641702,0.0189875835703958,0.129342793546198
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21042.Greatest number of times bowels opened per day,34840,0.0345446992072575,0.0440271739768572,-0.0517485617873825,0.120837960201898,0.432692024218193
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21043.Least number of times bowels opened per week,34783,0.0828163070641833,0.0433500209982908,-0.0021497340924667,0.167782348220833,0.0561066228249689
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21044.Average number of times bowels opened per day,34812,-0.0268755449640899,0.0488085631692558,-0.122540328775831,0.0687892388476513,0.581897372606425
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34887,0.030668756132545,0.0442290348248939,-0.0560201521242471,0.117357664389337,0.488068297558436
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34882,0.104057761213624,0.0443221607755436,0.0171863260935582,0.190929196333689,0.0189043130367174
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,30303,-0.143441817745494,0.0654382929682447,-0.271700871963254,-0.0151827635277346,0.0284139762851719
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34884,-0.00147276450746461,0.0464956588198898,-0.0926042557944485,0.0896587267795193,0.974731556517075
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34882,0.0848870703732993,0.0663334925492107,-0.0451265750231537,0.214900715769752,0.20067707237091
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34885,0.095396799298264,0.052510271616279,-0.00752333306964273,0.198316931666171,0.0692861528951704
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34883,0.0121986932325724,0.129356633206308,-0.241340307851791,0.265737694316936,0.924870336709568
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34885,-0.00929402261275107,0.0497656635646842,-0.106834723199532,0.08824667797403,0.85185559844195
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34885,0.135233174140662,0.051809189993507,0.0336871617533886,0.236779186527936,0.00906074584338954
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34633,0.027818586116585,0.0462333531611092,-0.0627987860791891,0.118435958312359,0.547386837734054
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34885,0.012067874298535,0.0456446708767985,-0.0773956806199901,0.10153142921706,0.791486388298729
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34886,0.100657657776812,0.0629435706194081,-0.0227117406372278,0.224027056190852,0.109810825714187
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34884,0.140387324674192,0.0440424133653894,0.0540641944780288,0.226710454870355,0.00143885074083364
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34882,0.103537592294886,0.0442440655873997,0.0168192237435823,0.190255960846189,0.0192939276345137
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X21100.Water hardness (USGS classification),52133,0.0198899299859675,0.027162323041852,-0.0333482231760623,0.0731280831479974,0.464014896171157
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2139.Age first had sexual intercourse,49400,0.0131968245667589,0.00278638896240399,0.00773550220044706,0.0186581469330707,2.18959209522208e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2149.Lifetime number of sexual partners,47365,0.000715806638228336,0.030574213230533,-0.0592096512936164,0.060641264570073,0.9813217493666
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22032.IPAQ activity group,47322,0.103449942115166,0.0296306080513172,0.0453739503345844,0.161525933895748,0.000481523074194139
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22033.Summed days activity,47907,0.00966863207919951,0.00266818309210756,0.0044389932186687,0.0148982709397303,0.000291043471384791
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22034.Summed minutes activity,47322,0.00943439327287619,0.00272948196461964,0.00408460862222169,0.0147841779235307,0.000548253542783421
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22037.MET minutes per week for walking,46537,0.00604735720689154,0.00268943980590335,0.000776055187320968,0.0113186592264621,0.024550291332084
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22038.MET minutes per week for moderate activity,47322,0.00517471244850943,0.0027964923697764,-0.000306412596252323,0.0106558374932712,0.0642642089020873
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22039.MET minutes per week for vigorous activity,47322,0.141514031077325,0.0296342728078569,0.0834308563739257,0.199597205780725,1.80477205524222e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22040.Summed MET minutes per week for all activity,46537,0.0117091014797816,0.00276815039462898,0.00628352670630883,0.0171346762532544,2.3467365578233e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X2217.Age started wearing glasses or contact lenses,46702,0.0057236506060523,0.00321663793908469,-0.000580959754553693,0.0120282609666583,0.0751892792249278
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X22501.Year ended full time education,31478,0.0145588153979982,0.0136244105729051,-0.0121450293248957,0.0412626601208922,0.285291408912108
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X22506.Tobacco smoking,31428,0.407523432980219,0.103013423330036,0.205617123253349,0.609429742707089,7.69040992693818e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50428,-0.0518772221887692,0.0595260974982586,-0.168548373285356,0.0647939289078177,0.383486988748734
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23098.Weight,52019,0.0346084974288644,0.00606759392185526,0.0227160133420281,0.0465009815157007,1.18320571575997e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23099.Body fat percentage,51997,0.00752827271487196,0.00587897602793796,-0.00399452029988644,0.0190510657296304,0.200365318769052
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23100.Whole body fat mass,51961,0.00873104888844587,0.00558962557752155,-0.00222461724349638,0.0196867150203881,0.118296984949544
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23101.Whole body fat-free mass,52014,0.0122158318634014,0.00518776804925892,0.00204780648685391,0.0223838572399489,0.0185426215206468
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23102.Whole body water mass,52019,0.0118481657436453,0.00518693635703062,0.00168177048386531,0.0220145610034253,0.0223653098639665
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23104.Body mass index (BMI),52019,-0.0264290167548996,0.0104324456699742,-0.046876610268049,-0.00598142324175021,0.0113032469155528
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23105.Basal metabolic rate,52017,0.0169264061166592,0.00555952804398395,0.00602973115045067,0.0278230810828677,0.00233223586411662
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23106.Impedance of whole body,52016,0.0132276535260129,0.00426287794400704,0.00487241275575905,0.0215828942962667,0.00191767871017947
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23107.Impedance of leg (right),52016,-0.00275926307149366,0.00351526289918441,-0.0096491783538951,0.00413065221090778,0.432496584819984
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23108.Impedance of leg (left),52015,-0.00453747004185139,0.00348995420602183,-0.0113777802856542,0.00230284020195139,0.193559609585506
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23109.Impedance of arm (right),52009,0.0230959840364938,0.0042729376759515,0.0147210261916288,0.0314709418813587,6.52701920567845e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23110.Impedance of arm (left),52014,0.0241020940067445,0.00426799525020954,0.0157368233163338,0.0324673646971552,1.64681267971895e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23111.Leg fat percentage (right),52015,-0.0235551293093266,0.00726528389664658,-0.0377950857467539,-0.00931517287189927,0.00118770191254312
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23112.Leg fat mass (right),52014,-0.0168396985238302,0.0075420137162313,-0.0316220454076436,-0.00205735164001687,0.0255709255865491
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23113.Leg fat-free mass (right),52014,0.0231083096861288,0.00557770432339874,0.0121760092122672,0.0340406101599903,3.43824297756445e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23114.Leg predicted mass (right),52013,0.0236896705550397,0.00559912648738712,0.012715382639761,0.0346639584703185,2.33433416994979e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23115.Leg fat percentage (left),52012,-0.0288106153191645,0.00751778453006499,-0.0435454729980919,-0.0140757576402371,0.000127212144899668
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23116.Leg fat mass (left),52012,-0.017880512119126,0.00784095776848415,-0.0332487893453549,-0.00251223489289708,0.0225914763049562
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23117.Leg fat-free mass (left),52010,0.023800193846928,0.00578668521781539,0.0124582908200098,0.0351420968738462,3.91788856503499e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23118.Leg predicted mass (left),52009,0.0234488078532179,0.0058088922198616,0.0120633791022891,0.0348342366041466,5.43495591350605e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23119.Arm fat percentage (right),52009,0.010543261849112,0.00648208772267892,-0.00216163008733871,0.0232481537855627,0.103849733773361
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23120.Arm fat mass (right),52007,0.0210005028429584,0.00633450539704591,0.00858487226474841,0.0334161334211684,0.000916751501916976
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23121.Arm fat-free mass (right),52006,0.00835314231004083,0.00519111322775389,-0.00182143961635679,0.0185277242364385,0.107600553741023
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23122.Arm predicted mass (right),52005,0.00825160271548141,0.00519246401726144,-0.00192562675835101,0.0184288321893138,0.112037828168786
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23123.Arm fat percentage (left),52001,0.0158730383415214,0.00662633327145524,0.00288542512946916,0.0288606515535737,0.0166065514002852
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23124.Arm fat mass (left),52000,0.0216636313093869,0.00630963582348012,0.00929674509536582,0.0340305175234079,0.000596875530411399
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23125.Arm fat-free mass (left),51996,0.00976950941500134,0.00527403057540169,-0.000567590512785978,0.0201066093427887,0.06398172333968
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23126.Arm predicted mass (left),51995,0.0104670792516192,0.00530240275360958,7.43698545444035e-05,0.020859788648694,0.0483885882011022
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23127.Trunk fat percentage,51992,0.012614210621447,0.00421689725976873,0.00434909199230028,0.0208793292505937,0.00277988644253671
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23128.Trunk fat mass,51988,0.0147084432374737,0.00459698383836787,0.00569835491427265,0.0237185315606747,0.00137777942748248
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23129.Trunk fat-free mass,51982,0.00693685430212879,0.0047243099381102,-0.0023227931765672,0.0161965017808248,0.142025313917091
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23130.Trunk predicted mass,51980,0.00651835243911262,0.00471741359875271,-0.0027277782144427,0.0157644830926679,0.167055143046761
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23400.Total Cholesterol,40058,0.0158060420045989,0.00356526875005108,0.00881811525449882,0.0227939687546991,9.33951570616469e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40058,0.0172526602828168,0.00346022012467448,0.0104706288384548,0.0240346917271788,6.2279093426075e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40058,0.0195233811250684,0.00347453573180449,0.0127132910907316,0.0263334711594052,1.95238866187018e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23403.VLDL Cholesterol,40058,0.0215657294110478,0.00342267906108873,0.0148572784513139,0.0282741803707817,3.03695687883052e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23404.Clinical LDL Cholesterol,40058,0.0134532922449689,0.00345895378265289,0.00667374283096925,0.0202328416589686,0.000100889286376567
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23405.LDL Cholesterol,40058,0.0145239529607663,0.003429478819205,0.00780217447512451,0.0212457314464081,2.29780258161297e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23406.HDL Cholesterol,40058,0.00172930794834883,0.00391384416053962,-0.00594182660630882,0.00940044250300648,0.65860810774219
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23407.Total Triglycerides,40058,0.0169573178861792,0.00351319208886796,0.010071461391998,0.0238431743803604,1.40040904703801e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23408.Triglycerides in VLDL,40058,0.0168432027629073,0.00356989216230631,0.00984621412478692,0.0238401914010277,2.40014306557526e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23409.Triglycerides in LDL,40058,0.0127059737439849,0.00335574149285636,0.00612872041798639,0.0192832270699833,0.00015343509643138
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23410.Triglycerides in HDL,40058,0.017596980811209,0.0033162067814193,0.0110972155196271,0.0240967461027908,1.13309452104199e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40058,0.0153904579089379,0.00353085251750911,0.00846998697462009,0.0223109288432558,1.31553027630698e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23412.Phospholipids in VLDL,40058,0.0203099454223876,0.00345997314212271,0.0135283980638271,0.0270914927809481,4.44384136313487e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23413.Phospholipids in LDL,40058,0.0131287034113895,0.00343278213538812,0.00640045042602878,0.0198569563967502,0.000131524568503153
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23414.Phospholipids in HDL,40058,0.00398654139941633,0.00367757771000886,-0.00322151091220104,0.0111945937110337,0.278375247376416
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23415.Total Esterified Cholesterol,40058,0.0147893944071504,0.00357878121362601,0.00777498322844344,0.0218038055858574,3.6060718928995e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40058,0.021751272504241,0.00342259700546174,0.015042982373536,0.0284595626349461,2.13723534711827e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40058,0.0154516546142818,0.00341615623852103,0.00875598838678055,0.022147320841783,6.13698322249507e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40058,0.000273959541779264,0.00390671366374833,-0.00738319923916747,0.007931118322726,0.944094780355159
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23419.Total Free Cholesterol,40058,0.0180539921282821,0.00352898664769236,0.0111371782988051,0.0249708059577592,3.15791315650038e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23420.Free Cholesterol in VLDL,40058,0.020837096227054,0.00344270364125454,0.0140893970901951,0.0275847953639129,1.45723037522774e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23421.Free Cholesterol in LDL,40058,0.0114682331562905,0.00347243463483321,0.00466226127201737,0.0182742050405635,0.000959835726353156
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23422.Free Cholesterol in HDL,40058,0.00625392069106608,0.00388147464155313,-0.00135376960637806,0.0138616109885102,0.107150639733712
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40058,0.018442680663021,0.00343985619710959,0.0117005625166862,0.0251847988093558,8.36794818006231e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23424.Total Lipids in VLDL,40058,0.020177256356452,0.0034930634756117,0.0133308519442531,0.027023660768651,7.77256030372749e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23425.Total Lipids in LDL,40058,0.0145635540468297,0.00342520432750541,0.00785015356491913,0.0212769545287403,2.13172295766726e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23426.Total Lipids in HDL,40058,0.00490737153089257,0.00375764227257285,-0.00245760732335022,0.0122723503851354,0.191580993141035
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40058,0.00676692048501328,0.00354475992770064,-0.00018080897327997,0.0137146499433065,0.0562806982881198
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23428.Concentration of VLDL Particles,40058,0.019786754349279,0.00341552085723761,0.0130923334690933,0.0264811752294647,7.03440179333607e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23429.Concentration of LDL Particles,40058,0.0170178487607487,0.00343179467019331,0.0102915312071698,0.0237441663143276,7.16193262285797e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23430.Concentration of HDL Particles,40058,0.00438396565988822,0.00354479697407566,-0.00256383640930006,0.0113317677290765,0.216204335621325
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40058,0.0158578719164521,0.00375147035795894,0.00850499001485254,0.0232107538180516,2.38010780494591e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23432.Average Diameter for LDL Particles,40058,-0.015190999278467,0.00342691365968584,-0.0219077500514513,-0.00847424850548277,9.36060464618395e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23433.Average Diameter for HDL Particles,40058,0.00704784155296019,0.00397367615461031,-0.000740563710076025,0.0148362468159964,0.0761427265991512
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23434.Phosphoglycerides,40046,0.0131146436102931,0.00349254143045176,0.00626926240660769,0.0199600248139786,0.000173918392704786
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40046,0.0135983658785792,0.0037624403401479,0.00622398281188927,0.020972748945269,0.000302142376022523
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23436.Total Cholines,40046,0.0137330333334015,0.00355106192424154,0.00677295196188807,0.0206931147049149,0.000110476074843604
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23437.Phosphatidylcholines,40046,0.0137061338983177,0.00354224965013765,0.00676332458404795,0.0206489432125875,0.000109562520864537
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23438.Sphingomyelins,40045,0.00998203713779869,0.00366444856582824,0.00279971794877534,0.017164356326822,0.00645614849602616
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23439.Apolipoprotein B,40058,0.0175020089744649,0.00344349802855902,0.0107527528384892,0.0242512651104406,3.76399520461451e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23440.Apolipoprotein A1,40058,0.0056528989604473,0.00365307809156863,-0.00150713409902721,0.0128129320199218,0.121778050791896
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40058,0.0120691859487097,0.00344458821690727,0.00531779304357142,0.0188205788538479,0.00045988839648671
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23442.Total Fatty Acids,40046,0.0165875368772632,0.00335483490970314,0.0100120604542451,0.0231630133002814,7.71564736864208e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23443.Degree of Unsaturation,40046,-0.00736916662751374,0.00371913146358086,-0.0146586642961322,-7.96689588952572e-05,0.0475609298733921
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23444.Omega-3 Fatty Acids,40046,0.0102511302703649,0.0034071173029607,0.00357318035656195,0.0169290801841679,0.00262736977373845
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23445.Omega-6 Fatty Acids,40046,0.0153997893913529,0.00340113184465577,0.00873357097582761,0.0220660078068782,6.00140412777753e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40046,0.015242710351685,0.003404038614052,0.00857079466814313,0.021914626035227,7.59206438108492e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40046,0.0155098602611719,0.00341406278671192,0.00881829719921658,0.0222014233231273,5.5877585365953e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23448.Saturated Fatty Acids,40046,0.016142222966712,0.003373710365516,0.00952975065030061,0.0227546952831233,1.72745626834089e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23449.Linoleic Acid,40046,0.0185415220042102,0.00342300725283452,0.0118324277886545,0.0252506162197659,6.15637844534562e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23450.Docosahexaenoic Acid,40046,0.00126009334511626,0.0035618664181723,-0.00572116483450145,0.00824135152473396,0.723513369716607
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40046,0.00321749415465798,0.00344480302639701,-0.00353431977708017,0.00996930808639612,0.350310619283173
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40046,-0.00939540542428117,0.00351876326558843,-0.0162921814248345,-0.00249862942372785,0.00759072425279388
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40046,-0.00916297651745499,0.00365881181529435,-0.0163342476754319,-0.00199170535947806,0.0122771211770037
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40046,0.00960955235532981,0.00373359534711727,0.00229170547497996,0.0169273992356797,0.010067460939423
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40046,0.00515653432326555,0.0033654438174918,-0.00143973555901838,0.0117528042055495,0.125492536506111
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40046,0.00497052102647406,0.00359917785382414,-0.00208386756702125,0.0120249096199694,0.16729320785925
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40046,-0.00905733656844913,0.00360430536468505,-0.0161217750832318,-0.00199289805366644,0.0119832335214036
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40046,-0.00995354065085994,0.00373334284234876,-0.0172708926218635,-0.00263618867985637,0.00768084875312631
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40044,-0.0055383313079585,0.00341722216394148,-0.0122360867492838,0.00115942413336679,0.105099004778356
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23460.Alanine,40054,0.00898461831713131,0.00331876989703542,0.00247982931894189,0.0154894073153207,0.0067921794188606
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23461.Glutamine,40014,0.021047784968822,0.00328082977444131,0.0146173586109171,0.027478211326727,1.44374094168902e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23462.Glycine,40039,0.0215433141334157,0.00344868588677462,0.0147838897953374,0.0283027384714939,4.29366629682736e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23463.Histidine,40040,-0.00530000513356299,0.00328266952271923,-0.0117340373980927,0.00113402713096671,0.106429590701439
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40046,0.00653020676288353,0.00350200998641765,-0.000333732810495059,0.0133941463362621,0.062241201264048
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23465.Isoleucine,40056,0.00190116576721218,0.00341471214508791,-0.00479167003716013,0.00859400157158449,0.577700983879065
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23466.Leucine,40057,0.00668392387586072,0.00352433494392585,-0.000223772614233954,0.0135916203659554,0.0579108868379817
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23467.Valine,40046,0.00722899499420782,0.0034861922188818,0.000396058245199499,0.0140619317432161,0.0381315382885489
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23468.Phenylalanine,40054,-0.00197119738647583,0.00331628251338532,-0.00847111111271106,0.0045287163397594,0.552253101716229
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23469.Tyrosine,40041,0.0104954270082417,0.00338320723939663,0.00386434081902429,0.0171265131974591,0.00192410744169714
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23470.Glucose,40030,-0.0210277458778703,0.00338342393007392,-0.0276592567808152,-0.0143962349749254,5.26055131733456e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23471.Lactate,40029,0.0204755605165251,0.00332160330854642,0.0139652180317741,0.0269859030012761,7.24477859298897e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23472.Pyruvate,40010,0.00245204186437299,0.00329231229197461,-0.00400089022789724,0.00890497395664322,0.456416755626595
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23473.Citrate,40057,0.0130081445772318,0.00336230780785106,0.00641802127384375,0.0195982678806199,0.000109794095995426
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23474.3-Hydroxybutyrate,39798,-0.0191113358215329,0.00325921804849168,-0.0254994031965766,-0.0127232684464892,4.61395868869842e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23475.Acetate,40044,-0.00364111684151393,0.00332119769622933,-0.0101506643261234,0.00286843064309555,0.272952256381121
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23476.Acetoacetate,40058,-0.0216098719169352,0.00325275451574481,-0.027985270767795,-0.0152344730660754,3.15948625605068e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23477.Acetone,40058,-0.0104482074819092,0.00327620338097535,-0.0168695661086209,-0.00402684885519749,0.00142977944981178
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23478.Creatinine,39629,0.0117865782417506,0.00411110670285971,0.00372880910414558,0.0198443473793556,0.00414920636531443
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23479.Albumin,40057,0.00812829964570613,0.00337365431166958,0.00151593719483376,0.0147406620965785,0.015992234330575
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23480.Glycoprotein Acetyls,40058,-0.00207622153302417,0.00353589422433818,-0.00900657421272701,0.00485413114667867,0.557088127586895
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40058,0.016798318539757,0.00355042846156846,0.00983947875508282,0.0237571583244312,2.24914740660801e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40058,0.0162939172496436,0.0035669875285043,0.00930262169377512,0.023285212805512,4.96085222614162e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40058,0.0159773950394966,0.00356884543175024,0.00898245799326617,0.0229723320857271,7.62485287753793e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40058,0.0191564819481312,0.0035411479185228,0.0122158320278265,0.0260971318684359,6.40330365124906e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40058,0.0206639439189628,0.00355426722187718,0.0136975801640835,0.027630307673842,6.22041248169926e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40058,0.0169354016756759,0.0035126960815625,0.0100505173558134,0.0238202859955384,1.43994277783193e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40058,0.0163055253806024,0.0035606607488569,0.00932663031284284,0.0232844204483619,4.69887000050286e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40058,0.018098220582726,0.00361480985318939,0.0110131932704748,0.0251832478949772,5.59566087583835e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40058,0.0182314117238865,0.0036192530036731,0.0111376758366872,0.0253251476110858,4.77120417454387e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40058,0.0189876234491601,0.00359399986322442,0.0119433837172403,0.02603186318108,1.28628051978299e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40058,0.0211336714827067,0.00353959222011617,0.0141960707312791,0.0280712722341344,2.41243843960929e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40058,0.0214114440203534,0.00350681408315732,0.0145380884173651,0.0282847996233418,1.04706358297372e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40058,0.0199037166695372,0.00356608345044264,0.0129141931066696,0.0268932402324048,2.42424247488281e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40058,0.0159875572589458,0.00365342908732284,0.00882683624779304,0.0231482782700986,1.2160994234095e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40058,0.0187460475620474,0.00357542734469892,0.0117382099664375,0.0257538851576573,1.59951572475369e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23496.Total Lipids in Large VLDL,40058,0.0184721800390593,0.00357969911380452,0.0114559697760024,0.0254883903021161,2.49518942696324e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23497.Phospholipids in Large VLDL,40058,0.0185599112572522,0.00359747063198675,0.0115088688185582,0.0256109536959462,2.50993224983e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23498.Cholesterol in Large VLDL,40058,0.0199925164977458,0.0035159692421233,0.0131012167831842,0.0268838162123075,1.32134690877496e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40058,0.0204933771023774,0.00345817140758653,0.0137153611435078,0.027271393061247,3.1655652314355e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40058,0.0189088088620655,0.00358101876297343,0.0118900120866376,0.0259276056374934,1.30647066593235e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23501.Triglycerides in Large VLDL,40058,0.0168923514407666,0.00360121528693403,0.00983396947837594,0.0239507334031573,2.74446541584432e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40058,0.0197676888601922,0.00341887510459434,0.0130666936551873,0.0264686840651971,7.52090946699674e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40058,0.0197967421721067,0.00343181493506787,0.0130703848993737,0.0265230994448397,8.13947667753395e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40058,0.019956668075936,0.00341777197207344,0.013257835010672,0.0266555011411999,5.34920436297263e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40058,0.0177860545072308,0.00345316412825831,0.0110178528158446,0.0245542561986171,2.62622963857049e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40058,0.0152294499600105,0.00349547866811223,0.0083783117705105,0.0220805881495104,1.32729080282244e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40058,0.0194491902928425,0.00341698608929745,0.0127518975578196,0.0261464830278655,1.27798210233231e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40058,0.0174450664734192,0.00352048556387789,0.0105449147682185,0.0243452181786198,7.29472069229566e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40058,0.0177643006623215,0.00343196697790157,0.0110376453856344,0.0244909559390086,2.29245570120653e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23510.Total Lipids in Small VLDL,40058,0.017965199874446,0.00342350103394782,0.0112551378479083,0.0246752619009838,1.56027152815148e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23511.Phospholipids in Small VLDL,40058,0.0175688434669478,0.00340145162001375,0.0109019982917208,0.0242356886421747,2.43156750738984e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23512.Cholesterol in Small VLDL,40058,0.0185216065517619,0.00340815237416704,0.0118416278983945,0.0252015852051293,5.57439910267242e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40058,0.018903235911039,0.00341367470616784,0.0122124334869501,0.025594038335128,3.11583452320664e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40058,0.017348294055257,0.00341004384398917,0.0106646081210382,0.0240319799894758,3.67041719737763e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23515.Triglycerides in Small VLDL,40058,0.0140708722713201,0.00346811941443388,0.00727335821902966,0.0208683863236105,4.98962446744529e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40058,0.0185501683001507,0.00342679677575283,0.0118336466196752,0.0252666899806263,6.2765425038942e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40058,0.0180512510705356,0.00341678741251597,0.0113543477420043,0.0247481543990669,1.28655401606463e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40058,0.0160872354198208,0.0033966557880771,0.00942979007518964,0.0227446807644519,2.19610100523572e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40058,0.0186183873892631,0.00354487416011386,0.0116704340354399,0.0255663407430862,1.52194444110154e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40058,0.0188537424797078,0.00359192587042545,0.011813567773674,0.0258939171857417,1.54921549834047e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40058,0.0171462954037028,0.00344282896668564,0.0103983506289989,0.0238942401784066,6.41416135872269e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40058,0.012671722636292,0.00336924762448033,0.00606799729231057,0.0192754479802735,0.000169834567341762
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23523.Concentration of IDL Particles,40058,0.0152146899492423,0.00352268796821205,0.0083102215315467,0.0221191583669379,1.57629543043298e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23524.Total Lipids in IDL,40058,0.0148086305869698,0.00360287394289707,0.00774699765889157,0.0218702635150481,3.97216594188508e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23525.Phospholipids in IDL,40058,0.0161000531455169,0.00360090849455555,0.00904227249618801,0.0231578337948458,7.83436346094737e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23526.Cholesterol in IDL,40058,0.0132521574255813,0.0036261185559342,0.00614496505595022,0.0203593497952123,0.000258356924479794
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40058,0.0131013910360434,0.00362028441381336,0.00600563358496926,0.0201971484871176,0.000296776635178504
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23528.Free Cholesterol in IDL,40058,0.013059185681646,0.00362734302469444,0.00594959335324491,0.0201687780100471,0.000318913588438552
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23529.Triglycerides in IDL,40058,0.0123076882494305,0.00332407178923555,0.00579250754252878,0.0188228689563322,0.000214114330766731
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23530.Concentration of Large LDL Particles,40058,0.0141711761944317,0.0034369812626069,0.00743469291972217,0.0209076594691412,3.75595007058257e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23531.Total Lipids in Large LDL,40058,0.0139667932426482,0.00345204048436408,0.0072007938932946,0.0207327925920018,5.23524270593239e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23532.Phospholipids in Large LDL,40058,0.0138895702682146,0.00346464966057359,0.0070988569334904,0.0206802836029389,6.12653031265475e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23533.Cholesterol in Large LDL,40058,0.013610282591605,0.00345808041861753,0.00683244497111465,0.0203881202120954,8.32694620259788e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40058,0.01388641707999,0.0034381234999384,0.0071476950201107,0.0206251391398692,5.3937878258066e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40058,0.0125237187543041,0.00351744726262315,0.00562952211956268,0.0194179153890454,0.000371270966017239
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23536.Triglycerides in Large LDL,40058,0.0114076512463162,0.00333603261456475,0.00486902732176924,0.0179462751708631,0.000628848480166386
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40058,0.0201796461330898,0.00341723303532572,0.0134818693838514,0.0268774228823282,3.59135710329895e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23538.Total Lipids in Medium LDL,40058,0.0153820327708976,0.00340077527691847,0.00871651322813738,0.0220475523136578,6.13742657634658e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23539.Phospholipids in Medium LDL,40058,0.0129569284251786,0.00339484781986027,0.0063030266982525,0.0196108301521048,0.000135781847325308
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23540.Cholesterol in Medium LDL,40058,0.0158128735713515,0.00340251113179769,0.00914395175302803,0.022481795389675,3.38772665578672e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40058,0.0173816873432748,0.00340693045735206,0.0107041036468647,0.0240592710396848,3.40129329816332e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40058,0.0105886741288928,0.00340478592614435,0.00391529371364991,0.0172620545441358,0.00187451092289603
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23543.Triglycerides in Medium LDL,40058,0.0133991208401322,0.0033831764241716,0.0067680950487559,0.0200301466315086,7.51082458138378e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23544.Concentration of Small LDL Particles,40058,0.0207223747106109,0.00342992071129102,0.0139997301164805,0.0274450193047413,1.55885670076605e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23545.Total Lipids in Small LDL,40058,0.0146698302941262,0.00342345462239208,0.00795985923423774,0.0213798013540147,1.83715005558172e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23546.Phospholipids in Small LDL,40058,0.00877418114733336,0.0034289389265725,0.00205346085125127,0.0154949014434155,0.0105105511845265
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23547.Cholesterol in Small LDL,40058,0.0156626988841399,0.00341969381594214,0.00896009900489327,0.0223652987633865,4.68111727681448e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40058,0.0183245714128171,0.00342035127088843,0.0116206829218758,0.0250284599037585,8.55290740464468e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40058,0.00724479802834254,0.00341348533892084,0.000554366764057681,0.0139352292926274,0.0338188803853259
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23550.Triglycerides in Small LDL,40058,0.0168157061531088,0.0034268319531232,0.0100991155249874,0.0235322967812303,9.33451954539839e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40058,0.0105798695712953,0.00400505207297603,0.00272996750826233,0.0184297716343284,0.00825871489919459
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40058,0.00455894951027511,0.00401727321411807,-0.0033149059893963,0.0124328050099465,0.256460493570689
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40058,0.00320872098858356,0.00397202517005445,-0.00457644834472317,0.0109938903218903,0.419200330531055
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40058,0.0026209365297616,0.00407795688829719,-0.0053718589713009,0.0106137320308241,0.520422524595962
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40058,0.00247762505358876,0.00412722621864335,-0.00561173833495222,0.0105669884421297,0.548306458388821
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40058,0.00273459446188657,0.00383752084972338,-0.00478694640357126,0.0102561353273444,0.476107269080377
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40058,0.0209359084704549,0.00326055286346106,0.0145452248580712,0.0273265920828386,1.39178008758378e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23558.Concentration of Large HDL Particles,40058,0.00645064132999005,0.00410046576592703,-0.00158627157122694,0.014487554231207,0.115703981151246
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23559.Total Lipids in Large HDL,40058,0.00363404945536011,0.00403894489229743,-0.00428228253354285,0.0115503814442631,0.36826552569132
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23560.Phospholipids in Large HDL,40058,0.00162921277490344,0.0039545634330392,-0.0061217315538534,0.00938015710366028,0.68035735964782
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23561.Cholesterol in Large HDL,40058,0.00210796296328149,0.00413562804700829,-0.00599786800885477,0.0102137939354177,0.610262947187386
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40058,0.00157582646446678,0.00414384169887358,-0.00654610326532544,0.00969775619425901,0.703741430146742
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40058,0.00356746306170815,0.00408074453478219,-0.00443079622646494,0.0115657223498812,0.382012141220895
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23564.Triglycerides in Large HDL,40058,0.0206985684762322,0.00329013283171427,0.0142499081260722,0.0271472288263922,3.2330661990096e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40058,0.00348570165308622,0.00361122430803135,-0.00359229799065522,0.0105637012968277,0.334438540956851
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23566.Total Lipids in Medium HDL,40058,0.0027554312943439,0.00355246015718586,-0.00420739061374038,0.00971825320242819,0.437972716900021
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23567.Phospholipids in Medium HDL,40058,0.00295229231907241,0.00349342693581367,-0.00389482447512239,0.00979940911326721,0.398067935619597
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23568.Cholesterol in Medium HDL,40058,-0.000652859244972844,0.003666268147543,-0.00783874481415712,0.00653302632421143,0.858668755941093
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40058,-0.00161263611985854,0.00365917793853815,-0.00878462487939331,0.00555935263967624,0.659428874997576
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40058,0.00307903464522986,0.00367591564375846,-0.00412576001653672,0.0102838293069964,0.402254347432035
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23571.Triglycerides in Medium HDL,40058,0.0162452523706694,0.00332672032244068,0.00972488053868565,0.0227656242026531,1.05339351304682e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23572.Concentration of Small HDL Particles,40058,0.00390053816925064,0.00330088229905765,-0.00256919113690234,0.0103702674754036,0.237355868126765
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23573.Total Lipids in Small HDL,40058,0.00491174492356247,0.0033142712610225,-0.00158422674804164,0.0114077165951666,0.138360156216016
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23574.Phospholipids in Small HDL,40058,0.00447267879375126,0.00331882478474373,-0.00203221778434645,0.010977575371849,0.177783568511444
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23575.Cholesterol in Small HDL,40058,0.00231982053598365,0.00329744248599519,-0.00414316673656692,0.00878280780853423,0.481741141813744
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40058,0.000631866930002542,0.00328668423865678,-0.00581003417776474,0.00707376803776983,0.847548342716139
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40058,0.00761751728366077,0.00334840209758858,0.00105464917238715,0.0141803853949344,0.0229206858763672
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23578.Triglycerides in Small HDL,40058,0.0146034428830096,0.003580729858472,0.00758521236040445,0.0216216734056147,4.55747715323625e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39291,-0.00457188941196622,0.00334807618711792,-0.0111341187387173,0.0019903399147849,0.172107285216357
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39291,0.00108933700458647,0.00334413951355913,-0.00546517644198943,0.00764385045116237,0.744621648274571
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39291,0.00487789907649585,0.00331185235083004,-0.00161333153113104,0.0113691296841227,0.140808841861555
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39291,-0.00537651259523995,0.00340161414157011,-0.0120436763127174,0.00129065112223747,0.113995316127653
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39291,-0.00048075764863335,0.00328055695606209,-0.00691064928251506,0.00594913398524836,0.883491054543404
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,39865,0.0129770273506988,0.00325870907196625,0.00658995756964495,0.0193640971317527,6.85647403350182e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,39865,0.000142580126172081,0.00363868757481036,-0.00698924752045622,0.00727440777280038,0.968743786021584
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,39865,-0.00110260053432833,0.00362400878571578,-0.00820565775433126,0.00600045668567461,0.760942260164112
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,39865,0.00630341678390311,0.00348429957222596,-0.000525810377659778,0.013132643945466,0.0704555425247639
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,39865,-0.00530850201722872,0.00353269971874029,-0.0122325934659597,0.00161558943150226,0.132942421748672
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40054,0.0121345728159612,0.00353221473086358,0.00521143194346863,0.0190577136884539,0.000593162070877365
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40054,0.00623345404097202,0.00340799167349666,-0.000446209639081424,0.0129131177210255,0.0674075586508055
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40054,0.00582398568083013,0.00355375772292812,-0.00114137945610898,0.0127893508177692,0.101269214150202
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40054,0.00567616469453396,0.00332315066701979,-0.000837210612824833,0.0121895400018928,0.0876430371033649
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40054,-0.00960065821632853,0.00327394398338901,-0.016017588423771,-0.00318372800888607,0.0033677610837804
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40058,0.00844169597716666,0.00358410950613802,0.00141684134513614,0.0154665506091972,0.0185190180827703
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40058,0.00195117758669887,0.00373405135474314,-0.00536756306859767,0.00926991824199542,0.601304086691988
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40058,0.000377019528491546,0.00374573498732285,-0.00696462104666124,0.00771866010364434,0.919827154364185
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40058,0.00602531146782909,0.00366509008604861,-0.00115826510082618,0.0132088880364844,0.100201055331857
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40058,-0.00359608033471018,0.00371190037592271,-0.0108714050715187,0.00367924440209832,0.332660627917055
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40058,7.70812315262776e-05,0.00356157975896593,-0.00690361509604695,0.00705777755909951,0.982733455817307
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40058,0.00571581006274034,0.00344757984622779,-0.00104144643586612,0.0124730665613468,0.0973530672091901
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40058,0.00764861517224045,0.00335229535173679,0.00107811628283634,0.0142191140616446,0.0225255622761871
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40058,0.00174821810998206,0.00358817024914302,-0.00528459557833826,0.00878103179830237,0.62611104075548
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40058,-0.00419505906718595,0.0034834002483599,-0.0110225235539714,0.00263240541959945,0.228491227133117
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40058,-0.0125668660758591,0.00347469915673334,-0.0193772764230565,-0.00575645572866179,0.000299315364700145
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40058,0.00591144131500709,0.00366230486661244,-0.00126667622355329,0.0130895588535675,0.106518404098728
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40058,0.00671222959642688,0.00370255317415229,-0.00054477462491162,0.0139692338177654,0.0698711261054513
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40058,-0.000600626589178129,0.00333801160918683,-0.00714312934318431,0.00594187616482806,0.857205502606508
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40058,-0.00353293693070977,0.00362764498695931,-0.01064312110515,0.00357724724373048,0.330124367409134
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40058,0.00272478574097429,0.00334976447620988,-0.00384075263239707,0.00929032411434564,0.415985775756554
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40058,-0.000234290570161177,0.00350761705548809,-0.00710921999891783,0.00664063885859548,0.946745889699868
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40058,0.000514443227885405,0.00346123694446669,-0.00626958118326931,0.00729846763904012,0.881847545100983
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40058,-0.000859478140945252,0.00344036075281765,-0.00760258521646784,0.00588362893457733,0.802728097808194
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40058,-0.00188609873562585,0.00354598343474109,-0.00883622626771838,0.00506402879646669,0.594804476616581
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40058,-0.00501791965877398,0.00335018606691628,-0.0115842843499299,0.00154844503238193,0.134203855855199
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40058,0.00594150396502043,0.00351445362594764,-0.000946825141836952,0.0128298330718778,0.0909341685401812
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40058,0.00683179829156888,0.00330520025758817,0.000353605786696066,0.0133099907964417,0.0387514480336899
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40058,-0.00191842636241394,0.00371333326894439,-0.00919655956954494,0.00535970684471705,0.605420207204038
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40058,-0.00393184474231663,0.00343919289561894,-0.0106726628177297,0.00280897333309648,0.252953217096265
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40058,-0.0236584482314825,0.00331343294251874,-0.0301527767988193,-0.0171641196641458,9.71796813250845e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40058,0.01772912120466,0.00346294069522508,0.0109417574420189,0.0245164849673012,3.09572812611146e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40058,0.0249063418273664,0.00343088368112314,0.018181809812365,0.0316308738423677,4.06294200058477e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40058,-0.0132760982504611,0.00359880942558052,-0.0203297647245989,-0.00622243177632324,0.000225851714837184
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40058,-0.00259952504366627,0.00336337172998517,-0.0091917336344372,0.00399268354710466,0.439597235876388
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40058,-0.0284017384827501,0.00338462457824751,-0.0350356026561153,-0.021767874309385,5.19596979206178e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40058,0.0182224581708904,0.00334275403849853,0.0116706602554333,0.0247742560863475,5.0725347906789e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40058,0.0295516516944579,0.00338953164041161,0.0229081696792511,0.0361951337096647,3.08822199304958e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40058,-0.0123673367606102,0.00342765803184234,-0.0190855465030212,-0.00564912701819923,0.00030937507013386
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40058,0.00677521905258723,0.00344835886936359,1.64356686345934e-05,0.0135340024365399,0.0494583672087781
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40053,-0.0011821657577848,0.00377065568737295,-0.00857265090503578,0.00620831938946617,0.753891723969811
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40053,-0.008589576415236,0.00346785678024289,-0.0153865757045121,-0.00179257712595994,0.013262585855163
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40053,-0.00542203558351598,0.00330561644450933,-0.0119010438147543,0.00105697264772231,0.10097273268146
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40053,-0.00385549631194971,0.00397855166041859,-0.0116534575663701,0.00394246494247072,0.332524581019521
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40053,0.0155188469280157,0.00368668804408208,0.0082929383616148,0.0227447554944166,2.57399421589174e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40058,-0.0171471008672543,0.00371381045020322,-0.0244261693496526,-0.00986803238485604,3.92095889394946e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40058,-0.000235622436660749,0.00378726787764335,-0.00765866747684171,0.00718742260352021,0.950392896838237
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40058,-0.00140398429947483,0.0036572240666805,-0.0085721434701686,0.00576417487121894,0.701062473217268
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40058,0.0028784117224789,0.00372117383375971,-0.00441508899169014,0.0101719124366479,0.439224500702292
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40058,0.0164508673238747,0.00357751634027675,0.00943893529693223,0.0234627993508171,4.28959262780773e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40058,-0.000271406121201521,0.00374518510525142,-0.00761196892749431,0.00706915668509127,0.942230355544969
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40058,-0.010916119740518,0.00366506665545877,-0.0180996503852171,-0.00373258909581877,0.00290164744359572
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40058,-0.0129580219397221,0.00350473702255136,-0.0198273065039228,-0.00608873737552145,0.000218634268652609
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40058,0.00470140658426525,0.00395130470310055,-0.00304315063381183,0.0124459638023423,0.234128097102182
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40058,0.0171090077661293,0.00355965685750018,0.010132080325429,0.0240859352068297,1.55078364058211e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40058,-0.00153691840421334,0.00333114529793815,-0.00806596318817211,0.00499212637974543,0.644533358941023
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40058,-0.00711893384080471,0.00332143860462395,-0.0136289535058677,-0.000608914175741763,0.0321015833379091
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40058,-0.00970038805592346,0.00326141297240223,-0.0160927574818318,-0.00330801863001509,0.00294100158610147
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40058,0.010367991809453,0.00361275911177167,0.00328698395038048,0.0174489996685254,0.00411228574976005
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40058,0.0144164189479781,0.00364452452991022,0.00727315086935403,0.0215596870266021,7.66557549077919e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,52041,0.00211877205062428,0.00281897497800572,-0.00340641890626693,0.00764396300751548,0.452291420742692
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,52041,0.000669633308547638,0.00275689518874859,-0.00473388126139959,0.00607314787849487,0.808089279064107
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50058,0.00130209006191698,0.00264920131940265,-0.00389034452411222,0.00649452464794618,0.623074937653563
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50058,-0.000655502560567123,0.00286240283390611,-0.00626581211502309,0.00495480699388885,0.818867360700839
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50058,0.00253786241156089,0.00284603272744964,-0.0030403617342404,0.00811608655736217,0.37255157703413
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50058,0.000847743913450163,0.00262712242166955,-0.00430141603302215,0.00599690385992247,0.746933241604708
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24009.Traffic intensity on the nearest road,52041,-0.0386972365565167,0.0587663537811547,-0.15387928996758,0.0764848168545465,0.510226730080666
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24010.Inverse distance to the nearest road,52041,0.00538376647392498,0.0024642694350428,0.000553798381241088,0.0102137345666089,0.0289167655201831
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24011.Traffic intensity on the nearest major road,52041,0.00188229878073535,0.00249082681801693,-0.00299972178257783,0.00676431934404853,0.449839985739524
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24012.Inverse distance to the nearest major road,52041,0.00144716539274236,0.00252067330913905,-0.00349335429317018,0.00638768507865489,0.565892140098577
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24013.Total traffic load on major roads,52041,0.00528060175718312,0.0408133646333092,-0.0747135929241028,0.0852747964384691,0.897054626374899
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24015.Sum of road length of major roads within 100m,52041,-0.0152714089999055,0.0395345124329465,-0.0927590533684806,0.0622162353686696,0.699291898775775
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,52041,0.000644037029035457,0.00282691571788254,-0.00489671777801432,0.00618479183608524,0.81978533063627
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,52041,0.000719387977555088,0.00282604894492634,-0.00481966795450055,0.00625844390961072,0.799067832382848
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,52041,0.00157459018450821,0.0027974879972957,-0.00390848629019136,0.00705766665920777,0.573535649168293
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51992,0.000581330889216206,0.00271413649874733,-0.00473837664832857,0.00590103842676098,0.830403321532108
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24020.Average daytime sound level of noise pollution,52041,0.00379787464542617,0.00246907831526523,-0.00104151885249368,0.00863726814334603,0.124017048439282
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24021.Average evening sound level of noise pollution,52041,0.00378151781683875,0.00246856112937056,-0.00105686199672755,0.00861989763040505,0.125565434992986
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24022.Average night-time sound level of noise pollution,52041,0.00379333614252763,0.00246909725618379,-0.0010460944795926,0.00863276676464786,0.124469887791483
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24023.Average 16-hour sound level of noise pollution,52041,0.00377829568457525,0.00246881951296941,-0.00106059056084479,0.00861718192999529,0.125927540341386
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24024.Average 24-hour sound level of noise pollution,52041,0.00378446780323655,0.00246888884386424,-0.00105455433073736,0.00862348993721046,0.125320894979633
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2405.Number of children fathered,36453,-0.0650436699730455,0.0435246354355981,-0.150351955426818,0.0202646154807268,0.135093428003147
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",48829,-0.00181667207189409,0.00293953853377336,-0.00757816759808988,0.0039448234543017,0.536572620343066
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",48829,0.00433918546104497,0.0026819246469786,-0.00091738684703309,0.00959575776912303,0.105688778955673
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24502.Water percentage, buffer 1000m",48829,0.0023559486036133,0.00262088353560814,-0.00278098312617865,0.00749288033340525,0.368707199397834
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24503.Greenspace percentage, buffer 300m",48829,-0.00190166979382979,0.00277798782696899,-0.00734652593468902,0.00354318634702944,0.493634684305264
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",48829,0.00212026973339892,0.00271565345806994,-0.00320241104441816,0.00744295051121599,0.434951902178878
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24505.Water percentage, buffer 300m",48829,0.000338993060564443,0.00263164389240279,-0.00481902896854502,0.0054970150896739,0.897505719326202
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52134,-0.0024863528466445,0.00278903657053406,-0.00795286452489126,0.00298015883160226,0.372682662567504
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52134,-0.00193181698630571,0.00263177811891373,-0.00709010209937663,0.0032264681267652,0.462933555221298
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24508.Distance (Euclidean) to coast,52134,0.000140561140003703,0.00252059537091824,-0.00479980578699606,0.00508092806700346,0.955529367540591
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,28732,0.00741430284961127,0.069017947141599,-0.127860873547923,0.142689479247145,0.914455672140416
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2704.Years since last cervical smear test,35781,0.099951397617075,0.0421712281219472,0.0172957904980586,0.182607004736091,0.0177975346421147
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2714.Age when periods started (menarche),39171,0.0523271672607162,0.0370531394053856,-0.0202969859738396,0.124951320495272,0.157905654409234
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2734.Number of live births,39658,-0.034475200470016,0.0354040039373705,-0.103867048187262,0.0349166472472301,0.33018786241062
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2744.Birth weight of first child,35719,0.120597652889045,0.0408257344381179,0.0405792133903344,0.200616092387757,0.00314339435452086
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2754.Age at first live birth,33668,0.00844760519292227,0.0040831521276741,0.000444627022681034,0.0164505833631635,0.0385822558716805
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2764.Age at last live birth,33645,0.00615705957589301,0.00409417927944111,-0.00186753181181157,0.0141816509635976,0.132650498534167
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2794.Age started oral contraceptive pill,37350,0.0100421342095526,0.00407878753938725,0.00204771063235357,0.0180365577867516,0.0138273743008085
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2804.Age when last used oral contraceptive pill,36142,-0.0155085555098124,0.00357295090939752,-0.0225115392922315,-0.00850557172739321,1.43266729010309e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2867.Age started smoking in former smokers,29417,0.00314590268984388,0.00548883704914207,-0.00761221792647458,0.0139040233061623,0.566569319339611
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36672,-0.00724872249934161,0.0475815348777807,-0.100508530859792,0.0860110858611085,0.878918666116338
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36667,0.0463200932749999,0.0528259749951525,-0.0572188177154989,0.149859004265499,0.380588298385249
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36689,0.0481398228091304,0.054091571752181,-0.0578796578251444,0.154159303443405,0.373499215009481
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36659,0.0429659751940596,0.0527730319749305,-0.0604691674768041,0.146401117864923,0.41556536956123
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28739.Difficulty with standing for long periods,36701,-0.119818828957372,0.0496422590763835,-0.217117656747083,-0.0225200011676599,0.0158077156700898
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28740.Difficulty with taking care of household responsibilities,36725,-0.112010657733767,0.0553837028446989,-0.220562715309377,-0.00345860015815704,0.0431507473976337
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28741.Difficulty learning a new task,36627,-0.108286299571486,0.0621666606577294,-0.230132954460635,0.0135603553176637,0.0815551185526055
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28742.Difficulty with joining in community activities,36184,-0.0802481615102471,0.0594564568534026,-0.196782816942916,0.036286493922422,0.177138207421172
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28743.Difficulty with being emotionally affected by health problems,36636,-0.0389039302046443,0.0512377778065226,-0.139329974705429,0.0615221142961401,0.447697803489683
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36723,-0.0799829703074858,0.0694992085530416,-0.216201419071447,0.0562354784564758,0.24981649614599
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,29260,-0.0451888594732101,0.0653444974082323,-0.173264074393345,0.0828863554469253,0.489250933559272
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2897.Age stopped smoking,29421,-0.0141409554588955,0.00661681030264736,-0.0271099036520844,-0.00117200726570671,0.0326312679837675
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35340,0.00631191530803851,0.00796903531929716,-0.00930739391778392,0.0219312245338609,0.428344897210539
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35340,-0.0114481650438032,0.00856207258863513,-0.0282298273175281,0.00533349722992162,0.181223436145538
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35340,0.0493037368606338,0.0288984625177168,-0.00733724967409122,0.105944723395359,0.0880160600519968
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35340,0.00711866952802215,0.0282774667176333,-0.0483051652385392,0.0625425042945835,0.801243807988407
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35340,0.0217225236394441,0.0305375354256722,-0.0381310457948734,0.0815760930737616,0.476888972620508
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35340,0.00444856692880241,0.0261465126851936,-0.0467985979341771,0.0556957317917819,0.864903056983983
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35340,-0.000115987275369629,0.0118508800864305,-0.0233437122447734,0.0231117376940342,0.992191215949541
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35340,0.0192728387762337,0.0217432865568114,-0.0233440028751166,0.061889680427584,0.375430754506066
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29002.Recent lack of interest or pleasure in doing things,35265,0.00478954333058917,0.0546388850393695,-0.102302671346575,0.111881758007753,0.93014992585938
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29003.Recent feelings of depression,35261,0.0431701806265022,0.0529432143394629,-0.0605985194788451,0.146938880731849,0.414857355242201
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35272,-0.0218938898099573,0.043172643656295,-0.106512271376296,0.062724491756381,0.612077518298083
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29005.Recent feelings of tiredness or low energy,35278,0.011819660583066,0.0439522805534189,-0.074326809301635,0.0979661304677669,0.787995872782241
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29006.Recent poor appetite or overeating,35280,0.108438932994047,0.0583607267764678,-0.0059480914878295,0.222825957475924,0.063183292219328
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29007.Recent feelings of inadequacy,35244,0.0693181809740424,0.0567273600460083,-0.0418674447161338,0.180503806664219,0.221750619000245
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29008.Recent trouble concentrating on things,35277,-0.0100748496199297,0.0563363771358326,-0.120494148806162,0.100344449566302,0.858071361313525
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35268,0.132125276010864,0.100271923355597,-0.0644076937661063,0.328658245787834,0.187640704382015
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29010.Recent thoughts of suicide or self-harm,35203,0.234771938467982,0.109694324853631,0.0197710617548649,0.4497728151811,0.0323568238285716
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#0.Substances taken for depression_None of options listed,32833,0.0119589383020863,0.0153876006222129,-0.018200758917451,0.0421186355216237,0.437072959052263
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),32833,0.0301151493879958,0.0271238024833899,-0.0230475034794484,0.08327780225544,0.266906013007237
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),32833,0.0223389046163348,0.0151022922386639,-0.00726158817144638,0.0519393974041159,0.139129157585905
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),32833,0.0402204800195324,0.0434231962346297,-0.0448889846003418,0.125329944639407,0.354344041518088
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),32833,0.0421449994444763,0.0257878026785652,-0.00839909380551154,0.0926890926944641,0.102231006373726
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),32833,0.0254343062492387,0.027865718423582,-0.029182501860982,0.0800511143594594,0.361400983842203
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),32833,0.00780953385135676,0.0317060231024239,-0.054334271429394,0.0699533391321076,0.805447334745451
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),32833,0.00706646303716794,0.0387553573489352,-0.0688940373667451,0.083026963441081,0.855323851677236
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),32833,0.0582233066483485,0.031056054661292,-0.00264656048778375,0.119093173784481,0.0608552913085667
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,32833,0.032883023106163,0.0155756048317798,0.00235483763587472,0.0634112085764514,0.0347837755848075
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,32833,0.0321969299406043,0.0227995364091544,-0.0124901614213382,0.0768840213025469,0.157933187926966
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,32833,-0.0109001086515404,0.0357475403978881,-0.0809652878314011,0.0591650705283204,0.760434823177778
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,32833,0.103147716043333,0.0448601111235286,0.0152218982412171,0.191073533845449,0.0215096756869971
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,32833,0.0280174202832816,0.0272460459021675,-0.0253848296849666,0.0814196702515298,0.303831076565765
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,32833,0.087826001174777,0.0461991536909828,-0.00272434005954934,0.178376342409103,0.0573300233640201
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,32833,-0.0128827402315816,0.0446273986790879,-0.100352441642594,0.0745869611794307,0.772838034344202
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,32833,0.0413623492524559,0.0238027955532611,-0.00529113003193583,0.0880158285368477,0.0822962831895283
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,32833,0.00747439849218657,0.0232275010018173,-0.0380515034713754,0.0530003004557486,0.747618603138776
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,32833,0.0450414113916812,0.0333239036095726,-0.0202734396830811,0.110356262466444,0.176529474461373
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29058.Recent feelings or nervousness or anxiety,35098,0.0352198798218518,0.0508537481500993,-0.0644534665523428,0.134893226196046,0.488592527730809
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29059.Recent inability to stop or control worrying,35104,0.0334266762542957,0.0532446551123392,-0.070932847765889,0.13778620027448,0.530151633492937
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29060.Recent worrying too much about different things,35095,0.0105724585322743,0.0487246930865603,-0.084927939917384,0.106072856981933,0.828225078903754
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29061.Recent trouble relaxing,35102,-0.00903425664322479,0.051155125151952,-0.109298301941051,0.091229788654601,0.859821759688325
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29062.Recent restlessness,35106,-0.0476898483705737,0.0714265940265061,-0.187685972662526,0.0923062759213783,0.504353905838566
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29063.Recent easy annoyance or irritability,35088,-0.00440842852458365,0.0512575873524778,-0.10487329973544,0.0960564426862729,0.93146367043721
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29064.Recent feelings of foreboding,35078,0.0636647999866157,0.0590869394051558,-0.0521456012474896,0.179475201220721,0.281290531603827
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,32833,0.00941492418822788,0.0155468082010486,-0.0210568198858273,0.0398866682622831,0.544805239977517
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,32833,-4.8508467119161e-05,0.0255915217401757,-0.0502078910778635,0.0501108741436252,0.998487661036279
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',32833,-0.00362631270299308,0.0334892896273554,-0.0692653203726096,0.0620126949666235,0.913773819020107
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,32833,0.0185615944989639,0.0373962257247739,-0.0547350079215929,0.0918581969195206,0.619660071085277
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#2.Symptoms of panic attack_Sweating,32833,0.0316980242068343,0.023299795073095,-0.0139695741364318,0.0773656225501004,0.173724208334488
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,32833,-0.00353810022812951,0.0251769155821427,-0.0528848547691291,0.0458086543128701,0.888244773166237
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,32833,0.024179073108335,0.025223677475806,-0.0252593347442448,0.0736174809609147,0.337792995283959
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,32833,0.0208140711382224,0.0227304350153865,-0.0237375814919352,0.06536572376838,0.359853216404645
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,32833,0.00118581327495848,0.0304981961395644,-0.0585906511585877,0.0609622777085046,0.96898579238272
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29076.Felt loved as a child,35053,0.00834215008606455,0.0452757044166164,-0.0803982305705036,0.0970825307426327,0.85381891585326
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29077.Physically abused by family as a child,35057,-0.00987031472235518,0.0583377149838583,-0.124212236090717,0.104471606646007,0.865648139312142
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29078.Felt hated by family member as a child,35043,-0.0558459636321082,0.0596084694546765,-0.172678563763274,0.0609866364990577,0.348840691172137
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29079.Sexually molested as a child,34961,-0.0479599680682098,0.0814090642598489,-0.207521734017514,0.111601797881094,0.555790625589643
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29080.Someone to take to doctor when needed as a child,35040,0.122514334905546,0.067972169691836,-0.0107111176904525,0.255739787501545,0.0715064261713341
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35044,-0.122748148021428,0.0806584409185092,-0.280838692221706,0.0353423961788501,0.128080848432753
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34982,-0.0110063412475276,0.0639411824833995,-0.136331058914991,0.114318376419935,0.863336671300259
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35051,0.0256004282015075,0.071045912951412,-0.11364956118326,0.164850417586275,0.718602386012796
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35012,0.0485461115423027,0.100005288751394,-0.147464254410429,0.244556477495035,0.627377033755912
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35012,-0.064898650114173,0.0974504211587727,-0.255901475585367,0.126104175357021,0.505446720710248
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29086.Experienced a violent or sexual assault,35050,0.0495735492475882,0.0786706847857853,-0.104620992932551,0.203768091427727,0.528615826422815
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29087.Experienced a life-threatening injury or illness,35058,-0.0920810058185122,0.0547822521751747,-0.199454220081855,0.0152922084448301,0.0928190328609268
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29088.Experienced a marital separation or divorce,35059,0.0815936820876483,0.0490264135162716,-0.0144980884042441,0.177685452579541,0.0960844551721687
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29089.Experienced the death of a spouse or partner,35070,0.0923569664845126,0.0780176596798329,-0.0605576464879599,0.245271579456985,0.236519066447585
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35056,0.0587622014827474,0.0605782368228987,-0.0599711426901341,0.177495545655629,0.332056655101074
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29091.Frequency of drinking alcohol,35065,0.0729182004973428,0.0415062581009719,-0.00843406538056211,0.154270466375248,0.078979197534706
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33944,0.022352965264133,0.0458642023450116,-0.0675408713320898,0.112246801860356,0.626004754704073
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33957,0.0930868005086806,0.0461318132847534,0.00266844647056393,0.183505154546797,0.0436339228294828
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29104.Ever used cannabis,35051,-0.0318699393301598,0.0541921513898675,-0.1380865560543,0.0743466773939806,0.556482801345292
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29108.Ever thought that life not worth living,35003,0.0594477828785135,0.050271142255572,-0.0390836559424076,0.157979221699435,0.23701558362843
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29109.Ever contemplated self-harm,35021,0.0834481439686494,0.0652057798176244,-0.0443551844738945,0.211251472411193,0.200654026715107
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29111.Ever self-harmed,35040,-0.0366719216213239,0.10233609979226,-0.237250677214153,0.163906833971505,0.720089777679521
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35046,-0.0169605648332796,0.0714475154662971,-0.156997695147222,0.123076565480663,0.812362512579473
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,33528,0.108284863110089,0.0319669481803435,0.045629644676616,0.170940081543562,0.000708396426351327
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,33528,0.0411290586018795,0.0249512588952148,-0.00777540883274142,0.0900335260365004,0.0993080117873836
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,33528,0.0219988393424464,0.0261863056582546,-0.0293263197477327,0.0733239984326255,0.400879004222022
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,33528,0.075017535792678,0.0348482188743626,0.00671502679892734,0.143320044786429,0.0313674378669107
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35038,0.00101115758240484,0.0460068182123719,-0.089162206113844,0.0911845212786537,0.982465554965972
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X29153.Pain or discomfort today,35054,-0.0729186712884747,0.0444158366490423,-0.159973711120598,0.0141363685436483,0.100674724627879
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29154.Anxiety or depression today,35054,0.0905485486358675,0.054589109222656,-0.0164461054405383,0.197543202712273,0.0971983990290102
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29166.Frequency of confiding in someone close,34811,-0.0524449307165258,0.0432663182154402,-0.137246914418789,0.0323570529857369,0.225484107862654
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35019,-0.0228611647416012,0.00824683085496613,-0.0390249532173348,-0.00669737626586755,0.00557856508025101
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35019,0.020264387811018,0.00820185300177439,0.00418875592754018,0.0363400196944958,0.0134993990512873
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35019,0.00961376156147215,0.0102014453217063,-0.0103810712690721,0.0296085943920164,0.346012327361183
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35019,0.0171868664984196,0.0121792992975472,-0.00668456012477294,0.0410582931216121,0.158227099194443
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35019,-0.0195336938097738,0.0188967974954552,-0.056571416900866,0.0175040292813184,0.301296997283891
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35019,-0.00153802406787726,0.00886591156746666,-0.0189152107401119,0.0158391626043574,0.862280331875833
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35018,-0.0138808523213913,0.0097150796953639,-0.0329224085243045,0.00516070388152194,0.153091302607138
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35018,0.012943577506068,0.0137367791289332,-0.013980509586641,0.039867664598777,0.346081432061818
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35018,0.0362303680466528,0.0221017931631915,-0.0070891465532025,0.079549882646508,0.101189362164788
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35018,0.0118002898897728,0.0218372151593042,-0.0310006518224634,0.054601231602009,0.588949080671264
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35018,0.000344522266649506,0.0290310796152614,-0.0565563937792629,0.0572454383125619,0.990531651267576
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35018,0.00989204822610594,0.0145737934307578,-0.0186725868981793,0.0384566833503911,0.497306620065613
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29171.Frequency of feeling 'in tune' with people,34830,0.0177958956045891,0.0524883374634368,-0.085081245823747,0.120673037032925,0.734582504073403
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29172.Freuency of feeling that lacks companionship,34968,0.130721416367231,0.0482409523880622,0.0361691496866294,0.225273683047833,0.00674351794016608
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29173.Frequency of feeling left out,34922,0.079901596366196,0.0496762779848683,-0.0174639084841459,0.177267101216538,0.10776613640541
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29174.Frequency of feeling isolated from others,34956,0.0970306156090169,0.0512916840410058,-0.00350108511135448,0.197562316329388,0.0585514268542037
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29175.Tendency to bounce back quickly after hard times,35037,-0.0343609941884554,0.0426453583872137,-0.117945896627394,0.0492239082504834,0.420410965907932
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29176.Ability to make it through stressful events,35037,0.023294361295411,0.0419134163823239,-0.0588559348139438,0.105444657404766,0.578376909496867
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29177.Quick recovery from stressful events,35037,-0.0160640798416096,0.0423848634874555,-0.0991384122770224,0.0670102525938032,0.70469127062
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29178.Hard to snap back when something bad happens,35037,0.00372045614251287,0.0421065455322489,-0.0788083731006949,0.0862492853857206,0.929593612137418
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29179.Comes through difficult times with little trouble,35037,-0.00698081018689823,0.0424659212508659,-0.0902140158385955,0.076252395464799,0.869430122862918
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29180.Tendency to take a long time to get over setbacks,35037,0.0117695264483193,0.0423126636921174,-0.0711632943882309,0.0947023472848695,0.780897662244969
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29181.General happiness,34968,0.0549435089517685,0.0441759951533127,-0.0316414415487245,0.141528459452261,0.213621052277413
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29182.Belief that own life is meaningful,34865,-0.0334462346050257,0.0437452102116848,-0.119186846619928,0.0522943774098764,0.444544592037018
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28951,0.0154516943265332,0.0629368778109261,-0.107904586182882,0.138807974835948,0.806070708329417
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2946.Father's age,34207,0.00470128148457358,0.00603974882153486,-0.00713662620563475,0.0165391891747819,0.4363567949931
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2966.Age high blood pressure diagnosed,29121,-0.00817339465596011,0.00999968694125299,-0.027772781060816,0.0114259917488957,0.413756853348609
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30000.White blood cell (leukocyte) count,51555,-0.0543451772907627,0.00257131263819065,-0.0593849500616163,-0.049305404519909,2.26221742537643e-98
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51555,0.0322325342281172,0.00304947621392592,0.0262555608488224,0.038209507607412,4.6092642445464e-26
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30020.Haemoglobin concentration,51555,0.0202134653781836,0.00325518094864194,0.0138333107188454,0.0265936200375218,5.38639091513536e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30030.Haematocrit percentage,51555,0.0202576644146745,0.00318620552927764,0.0140127015772903,0.0265026272520587,2.07679222920029e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30040.Mean corpuscular volume,51555,-0.0213586948204996,0.00258850074141449,-0.026432156273672,-0.0162852333673272,1.63459258402217e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51554,-0.0203928829542223,0.00259393980923571,-0.0254770049803243,-0.0153087609281203,3.92536601283054e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51554,-0.0017765403826183,0.00252715214480311,-0.0067297585864324,0.0031766778211958,0.482073390773555
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51555,-0.0187344829428968,0.00246490571489834,-0.0235656981440976,-0.0139032677416961,3.04343213083107e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30080.Platelet count,51555,-0.0176016709194938,0.00260820008326164,-0.0227137430826867,-0.012489598756301,1.52231917261591e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30090.Platelet crit,51555,-0.0151599236031368,0.00267399858451487,-0.0204009608287859,-0.00991888637748765,1.44736781312251e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51555,0.00923070005017214,0.00251530731107752,0.0043006977204602,0.0141607023798841,0.000243186128093722
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30110.Platelet distribution width,51555,0.0146120761974353,0.00248899079506626,0.00973365423910546,0.0194904981557652,4.38947526602134e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30120.Lymphocyte count,51518,-0.0291444545903524,0.0026314573757413,-0.0343021110468054,-0.0239867981338995,1.89532410535054e-28
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30130.Monocyte count,51518,-0.0248087095595483,0.00262320339412774,-0.0299501882120386,-0.0196672309070579,3.3982990445953e-21
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30140.Neutrophill count,51518,-0.0513365878885034,0.0025476131971488,-0.0563299097549151,-0.0463432660220918,1.16567040250425e-89
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30150.Eosinophill count,51518,0.012561489954748,0.00251619249762971,0.00762975265939374,0.0174932272501022,6.00389170750897e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30160.Basophill count,51518,-0.249518094106104,0.0297513267819626,-0.30783069459875,-0.191205493613457,5.2307165082944e-17
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30170.Nucleated red blood cell count,51518,0.435319346152098,0.133724971893838,0.173218401240177,0.69742029106402,0.0011339553957154
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30180.Lymphocyte percentage,51518,0.0157930426443223,0.0025863066900082,0.0107238815319062,0.0208622037567384,1.03254962148292e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30190.Monocyte percentage,51518,0.0162222691088824,0.00259264658889892,0.0111406817946405,0.0213038564231243,3.98123711609472e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30200.Neutrophill percentage,51518,-0.0234581548587456,0.00254478569384689,-0.0284459348186855,-0.0184703748988057,3.23178405479358e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30210.Eosinophill percentage,51518,0.0323077688872174,0.00247816851919033,0.0274505585896044,0.0371649791848305,9.81052150522026e-39
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30220.Basophill percentage,51518,-0.00564150136329103,0.00246982096677911,-0.0104823504581781,-0.000800652268403978,0.0223688361003352
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30230.Nucleated red blood cell percentage,51517,0.430301916063722,0.134089310781786,0.167486866931421,0.693116965196023,0.00133317152247552
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30240.Reticulocyte percentage,51066,-0.0108060640824638,0.00265498762657137,-0.0160098398305437,-0.00560228833438394,4.71256986408258e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30250.Reticulocyte count,51066,-0.00492039754233476,0.00272256155026964,-0.0102566181808633,0.000415823096193725,0.0707315917745493
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30260.Mean reticulocyte volume,51066,-0.0187751885618916,0.00256728829521591,-0.0238070736205148,-0.0137433035032684,2.67979143282242e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30270.Mean sphered cell volume,51066,-0.0228604082967559,0.00257844995543836,-0.0279141702094151,-0.0178066463840968,8.0392434386027e-19
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30280.Immature reticulocyte fraction,51066,-0.0188077274575109,0.00267841686456017,-0.0240574245120488,-0.0135580304029729,2.23919947267323e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51066,-0.0167857400209278,0.00271447007502628,-0.0221061013679793,-0.0114653786738763,6.34664278143407e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30300.High light scatter reticulocyte count,51066,-0.0121923525154917,0.00276139244594311,-0.0176046817095402,-0.00678002332144318,1.01262316041307e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30500.Microalbumin in urine,32134,-0.0200914502528937,0.00480390691303955,-0.0295071078024512,-0.0106757927033362,2.91534121119687e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51672,0.00714321561406869,0.00265167360954092,0.00194593533936848,0.0123404958887689,0.00706739446708431
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30520.Potassium in urine,51609,0.0140024628137933,0.00245495684680901,0.00919074739404761,0.0188141782335389,1.18389658101625e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30530.Sodium in urine,51611,0.00914634842048873,0.00255448491846468,0.00413955798029797,0.0141531388606795,0.000343514962402348
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30600.Albumin,48854,0.00247322352508612,0.00275482741306561,-0.00292623820452246,0.00787268525469471,0.369312548085232
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30610.Alkaline phosphatase,51153,0.0444265845960907,0.00258356248318704,0.0393628021290441,0.0494903670631373,6.35038396948051e-66
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30620.Alanine aminotransferase,51143,-0.00619299153070528,0.002742626371031,-0.011568539217926,-0.000817443843484513,0.0239503170047576
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30630.Apolipoprotein A,48718,0.00999072328381721,0.00299747909693468,0.00411566425382523,0.0158657823138092,0.000860274012097265
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30640.Apolipoprotein B,50989,0.00936533431262993,0.00263789469274163,0.00419506071485634,0.0145356079104035,0.000385434063527854
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30650.Aspartate aminotransferase,51062,0.00977434714126639,0.00257529512192061,0.004726768702302,0.0148219255802308,0.000147708478605409
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30660.Direct bilirubin,46904,0.00681969359426701,0.00284372259682382,0.00124599730449232,0.0123933898840417,0.0164856979733523
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30670.Urea,51144,0.0177173361874269,0.00270187212836674,0.0124216668158281,0.0230130055590257,5.57209513083526e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30680.Calcium,48850,-0.0024184268361241,0.00268419188966832,-0.00767944293987402,0.00284258926762581,0.367602956159637
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30690.Cholesterol,51158,0.0220313427274487,0.00270707937941522,0.0167254671437949,0.0273372183111025,4.17369351553415e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30700.Creatinine,51147,0.0106784711378443,0.00327060911387255,0.00426807727465413,0.0170888650010345,0.00109606918190254
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30710.C-reactive protein,51073,-0.00114360590057647,0.00281542635590963,-0.00666184155815934,0.00437462975700639,0.684604141588452
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30720.Cystatin C,51151,0.0500875276988313,0.00300608932337357,0.0441955926250191,0.0559794627726435,5.015985376714e-62
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30730.Gamma glutamyltransferase,51144,-0.0184091810028384,0.00279525700974709,-0.0238878847419427,-0.0129304772637341,4.6046629411274e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30740.Glucose,48816,-0.0100962582803849,0.00272886608480041,-0.0154448358065937,-0.00474768075417614,0.000216232764204963
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50910,-0.0271756972483339,0.00272622854188109,-0.0325191051904208,-0.0218322893062469,2.30343494072012e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30760.HDL cholesterol,48833,0.0097276623301015,0.00317594802312969,0.00350280420476731,0.0159525204554357,0.0021942472919873
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30770.IGF-1,51030,-0.0415596190034773,0.00265420108280742,-0.0467618531257799,-0.0363573848811748,5.09541701972183e-55
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30780.LDL direct,51100,0.0188701375466988,0.00267938815259311,0.0136185367676163,0.0241217383257813,1.93018667487959e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30790.Lipoprotein A,45708,0.00234520592721429,0.00282904847750692,-0.00319972908869927,0.00789014094312785,0.407128517041882
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30810.Phosphate,48789,0.00464199679632599,0.00268334881534878,-0.00061736688175762,0.00990136047440961,0.0836557469708521
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30830.SHBG,48599,-0.021494912950714,0.00310731811616101,-0.0275852564583896,-0.0154045694430385,4.7083835892165e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30840.Total bilirubin,51051,0.0175558716834177,0.00262544338219248,0.0124100026543205,0.022701740712515,2.32485109338651e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30850.Testosterone,48968,-0.0219537128302534,0.00437640271826739,-0.0305314621580575,-0.0133759635024493,5.30122317648073e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30860.Total protein,48834,-0.0168457964508458,0.00272082812517838,-0.0221786195761954,-0.0115129733254962,6.05522123863201e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30870.Triglycerides,51134,0.0168799422544603,0.00269979708782211,0.0115883399623289,0.0221715445465916,4.10440928549523e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30880.Urate,51122,0.0238752616917896,0.00324676198697014,0.0175116081973282,0.0302389151862511,1.98428167371382e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30890.Vitamin D,50046,-0.00198714860926717,0.00280851280914056,-0.00749183371518267,0.00351753649664833,0.4792342847614
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3137.Number of measurements made,50173,-0.00416701412051419,0.033814511805803,-0.070443457259888,0.0621094290188597,0.901924697530509
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3143.Ankle spacing width,40089,0.00885846523929921,0.00459552040944994,-0.000148754763222677,0.0178656852418211,0.0539185344487441
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40088,0.0015887354871104,0.00352613049566677,-0.00532248028439646,0.00849995125861726,0.652312284972479
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3146.Speed of sound through heel,40089,-0.000345466398131917,0.00342320013364583,-0.00705493866007774,0.00636400586381391,0.919615899384955
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40089,0.000220516673534789,0.00345755987048064,-0.00655630067260726,0.00699733401967684,0.949147684775644
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3148.Heel bone mineral density (BMD),40079,0.000884682756967698,0.00346178039259266,-0.00590040681251391,0.00766977232644931,0.798296044048815
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X3526.Mother's age at death,35440,-0.000252713576200772,0.00464353311572988,-0.00935403848303134,0.0088486113306298,0.956599338247747
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X3581.Age at menopause (last menstrual period),30442,0.00460707318094796,0.00628586495918556,-0.00771322213905573,0.0169273685009517,0.463629726736442
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",30412,0.00665905662502778,0.00598280767852009,-0.00506724642487161,0.0183853596749272,0.265735502629579
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4100.Ankle spacing width (left),32890,0.0160357834874529,0.00614048908292552,0.00400042488491891,0.0280711420899869,0.009029955648282
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4101.Heel broadband ultrasound attenuation (left),32889,0.00206129967520184,0.00474626091738425,-0.00724137172287128,0.011363971073275,0.664081202167834
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4103.Speed of sound through heel (left),32890,0.00193538640037603,0.00463241167003631,-0.00714414047289513,0.0110149132736472,0.676108840061188
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",32890,0.00210388439368339,0.00467367594534819,-0.00705652045919908,0.0112642892465658,0.652608592997068
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4105.Heel bone mineral density (BMD) (left),32882,0.00189995094735458,0.0046837447910768,-0.00728018884315596,0.0110800907378651,0.685010993476658
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",32890,0.00211284975737006,0.00467372929372688,-0.00704765965833463,0.0112733591730747,0.651229882760449
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4119.Ankle spacing width (right),32881,0.0189766680139788,0.00601020251994794,0.00719667107488089,0.0307566649530768,0.00159702369153172
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4120.Heel broadband ultrasound attenuation (right),32881,0.00453088511412388,0.00477114308657308,-0.00482055533555936,0.0138823255638071,0.342318857284121
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4122.Speed of sound through heel (right),32881,0.00439422223513713,0.00464172503891091,-0.00470355884112825,0.0134920033114025,0.343827883084896
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",32881,0.00462923642443109,0.00468872368874798,-0.00456066200551494,0.0138191348543771,0.323515848608667
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4124.Heel bone mineral density (BMD) (right),32871,0.00405381421421811,0.00470800230788273,-0.00517387030923204,0.0132814987376683,0.389234722763524
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",32881,0.00462901425470772,0.00468874363858624,-0.0045609232769213,0.0138189517863367,0.323541128432023
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4194.Pulse rate,33185,-0.0237152364386845,0.00446954573496355,-0.032475546079213,-0.0149549267981559,1.14653327167531e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4195.Pulse wave reflection index,33185,0.0179056536149339,0.004375562197658,0.00932955170752423,0.0264817555223436,4.30908656107624e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4196.Pulse wave peak to peak time,33180,0.00398606131880564,0.00470823252253044,-0.00524207442535401,0.0132141970629653,0.397231364355132
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4198.Position of the pulse wave peak,33185,-0.0045994356726919,0.00450781608234879,-0.0134347551940955,0.00423588384871172,0.307601006619138
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4199.Position of pulse wave notch,33185,-0.0257214672529986,0.00441951765355338,-0.0343837218539632,-0.017059212652034,6.08004716217775e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4200.Position of the shoulder on the pulse waveform,33185,-0.0104936549243761,0.00461878579817881,-0.0195464750888066,-0.00144083475994562,0.0231121455581872
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4269.Number of triplets attempted (left),33049,0.00607547374386727,0.156757871302469,-0.301169954008972,0.313320901496707,0.969084925914841
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4270.Volume level set by participant (left),32961,-0.0407342452387738,0.0463248395901658,-0.131530930835499,0.0500624403579511,0.379252337140529
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4276.Number of triplets attempted (right),33058,-0.0537216013448504,0.153230211260241,-0.354052815414923,0.246609612725222,0.725900956069411
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4277.Volume level set by participant (right),32956,-0.0639809399701265,0.046185327532395,-0.154504181933621,0.0265423019933678,0.165992049213541
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X4288.Time to answer,33217,-0.00395965867909189,0.0050640820437685,-0.0138852594848781,0.00596594212669437,0.434286986807472
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X4290.Duration screen displayed,33217,-0.00770462437707772,0.00451376937753441,-0.0165516123570452,0.00114236360288973,0.0878708774845182
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X46.Hand grip strength (left),52388,0.00802327328193808,0.00352117039584144,0.00112177930608886,0.0149247672577873,0.022699319234281
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X47.Hand grip strength (right),52366,0.0041284695871041,0.0034904439947389,-0.00271280064258415,0.0109697398167923,0.23690141656743
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X48.Waist circumference,52446,-0.0330163016985495,0.00552388336878666,-0.0438431131013713,-0.0221894902957276,2.29962055840407e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X4803.Tinnitus,33001,-0.0560845914147734,0.0563902748996439,-0.166609530218075,0.0544403473885287,0.319967329530428
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X4825.Noisy workplace,33140,0.0184103877769169,0.0620057648397023,-0.1031209113089,0.139941686862733,0.766538714116587
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X4836.Loud music exposure frequency,33078,-0.0710244689086272,0.0671093408333156,-0.202558776941926,0.0605098391246714,0.289928410938923
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X49.Hip circumference,52442,0.0353008903565796,0.00435888921883696,0.0267574674876591,0.0438443132255,5.77904256569087e-16
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X50.Standing height,52418,0.0230359122884403,0.00346234418190864,0.0162497176918994,0.0298221068849812,2.91828786428086e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X5057.Number of older siblings,32341,-0.014525974523946,0.0484887368183176,-0.109563898687848,0.0805119496399564,0.764509308568398
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X51.Seated height,52278,0.0198415372109026,0.00320879628806521,0.0135522964862948,0.0261307779355104,6.35556524015005e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5181.Ever had eye surgery,30177,0.0565820010366143,0.122078919409325,-0.182692681005662,0.29585668307889,0.643031252054618
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5186.Duration visual-acuity screen displayed (right),30162,0.00104696857674021,0.00552615679048533,-0.00978429873261103,0.0118782358860915,0.849740827441699
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5188.Duration visual-acuity screen displayed (left),30160,0.00512212034383932,0.00546948976009676,-0.00559807958595033,0.015842320273629,0.349057055040444
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5190.Duration at which refractometer first shown (right),30105,0.00584262802777273,0.00541009448110149,-0.00476115715518618,0.0164464132107316,0.280206440259607
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5193.Duration at which refractometer first shown (left),30103,0.00325946287617665,0.00542004574238768,-0.00736382677890319,0.0138827525312565,0.547614185798476
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5199.logMAR, initial (right)",30138,-0.106389431168022,0.0569746157481401,-0.218059678034377,0.00528081569833226,0.0619044878751752
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5200.Final number of letters displayed (right),30138,-0.686117845283875,0.4444620860679,-1.55726353397696,0.185027843409209,0.122710504947456
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5201.logMAR, final (right)",30084,-0.010199681644354,0.00524264233090161,-0.0204752606129212,7.58973242131356e-05,0.051757016696176
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5202.Number of rounds to result (right),30138,-0.0115224934989048,0.0549661622915021,-0.119256171590249,0.0962111845924393,0.833964173244196
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5206.logMAR, initial (left)",30134,-0.0686906617523544,0.0568450150468418,-0.180106891244164,0.0427255677394554,0.226944768194816
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5207.Final number of letters displayed (left),30134,0.711773119943751,0.373893288800544,-0.0210577261053156,1.44460396599282,0.0569976182541091
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5208.logMAR, final (left)",30085,-0.0123755962633875,0.00524777231795138,-0.0226612300065722,-0.00208996252020282,0.0183917195175751
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5209.Number of rounds to result (left),30130,0.0852879788039723,0.0552540023157185,-0.0230098657348361,0.193585823342781,0.122745029631711
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",29889,0.00323955446081284,0.00547053513479897,-0.00748269440339315,0.0139618033250188,0.553750680378701
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",29889,0.00203734152053656,0.00537467011337029,-0.00849701190166921,0.0125716949427423,0.704654023428021
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5256.Corneal hysteresis (right),29889,-0.00353577479808278,0.00550368748769505,-0.0143230022739651,0.00725145267779951,0.520613636834007
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5257.Corneal resistance factor (right),29889,-0.00175394911477261,0.00540673842314954,-0.0123511564241457,0.00884325819460048,0.745646029952149
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",29868,-0.00121364878396395,0.00549935911839663,-0.0119923926560213,0.00956509508809346,0.825341994075548
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",29868,0.000577449842460891,0.00537335058698288,-0.00995431730802555,0.0111092169929473,0.914423276938525
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5264.Corneal hysteresis (left),29868,0.00267456480099915,0.00547562065370073,-0.00805765168025428,0.0134067812822526,0.625249232823731
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5265.Corneal resistance factor (left),29868,0.00193949648873161,0.00536881096522751,-0.0085833730031143,0.0124623659805775,0.717923386546788
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,29981,0.299358481212505,0.228921709331952,-0.149328069078122,0.748045031503131,0.191027817261245
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52346,0.00690827384424878,0.0150924324746698,-0.022672893806104,0.0364894414946015,0.647149222030779
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52346,0.00569702191394284,0.0167977018024575,-0.0272264736188739,0.0386205174467596,0.734495585573983
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52346,-0.0948401213437935,0.039422322913577,-0.172107874254404,-0.0175723684331826,0.0161457840497473
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52346,-0.0292388743168779,0.00694584526609218,-0.0428527310384186,-0.0156250175953372,2.56665319024292e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52346,0.0240275056976769,0.00622851137753496,0.0118196233977084,0.0362353879976454,0.000114727692427519
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38028,-0.000408472230011415,0.00712678827980358,-0.0143769772584264,0.0135600327984036,0.954295039765566
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38028,0.00312678993542733,0.0252693756345896,-0.0464011863083683,0.0526547661792229,0.901524229903101
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38028,0.0123964177877789,0.012115058600724,-0.0113490970696401,0.036141932645198,0.306219454585235
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38028,0.00357536628946627,0.00768993120173423,-0.0114968988659328,0.0186476314448654,0.641980668672191
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52430,0.00322154476115767,0.0141249240293429,-0.0244633063363544,0.0309063958586697,0.819589417909701
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52430,0.00322154476115767,0.0141249240293429,-0.0244633063363544,0.0309063958586697,0.819589417909701
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52430,0.00522927890659879,0.0103275057480834,-0.0150126323596447,0.0254711901728423,0.612618520297319
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52430,0.0161705310197186,0.0160911068349603,-0.0153680383768035,0.0477091004162408,0.314936224714887
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52430,-0.0231171273230404,0.0393137886999657,-0.100172153174973,0.0539378985288925,0.55652636255997
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52430,-0.00257278385149232,0.0276575732962375,-0.0567816275121178,0.0516360598091331,0.925886130616521
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52430,-0.0942224995958638,0.0418310173267871,-0.176211293556366,-0.0122337056353611,0.024301067588377
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52345,-0.0021523259893567,0.00790132508182114,-0.0176389231497261,0.0133342711710127,0.785315957012816
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52345,-0.0181679736037234,0.0136426074741092,-0.0449074842529775,0.00857153704553068,0.182966716754527
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52345,0.0172369546149055,0.00663763397658803,0.00422719202079299,0.0302467172090181,0.00941307319205834
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52345,-0.0275022374272876,0.0125504191561476,-0.052101058973337,-0.00290341588123821,0.0284352556640685
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52345,-0.0203684274093702,0.0108561824481709,-0.0416465450077851,0.000909690189044729,0.0606373067021333
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52345,-0.0148288994421051,0.00883905635194621,-0.0321534498919196,0.00249565100770951,0.0934251667945854
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,30173,-0.0664300069122215,0.0236601683299183,-0.112803936838861,-0.0200560769855815,0.00500540689953746
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,30173,-0.0268972049139695,0.0205281339449284,-0.0671323474460292,0.0133379376180903,0.190155364305129
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,30173,-0.0298380471775275,0.0257176024617586,-0.0802445480025744,0.0205684536475193,0.246003588118781
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,30173,0.0198224772184299,0.0211840389781849,-0.0216982391788125,0.0613431936156723,0.349449557686682
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52295,0.0375794110430815,0.0220196319244468,-0.00557906752883432,0.0807378896149973,0.0879013704221558
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52295,0.0120527858670976,0.0316624594584066,-0.0500056346713794,0.0741112064055746,0.703454786422265
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52295,0.0644206594366224,0.0654777015649864,-0.063915635630751,0.192756954503996,0.325194467018996
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52295,-0.067331484382869,0.0563507155707299,-0.1777788869015,0.0431159181357616,0.232149838112902
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52295,0.0124074515783732,0.0204628278238083,-0.027699690956291,0.0525145941130374,0.544293175567124
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52295,0.00935458588959016,0.0259316587864066,-0.0414714653317668,0.0601806371109472,0.718296519561089
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52295,0.0140338340593262,0.0106620030674254,-0.00686369195282764,0.0349313600714801,0.188101621400839
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",33703,0.0376854315744401,0.0207116339485282,-0.00290937096467521,0.0782802341135553,0.0688610310294027
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",33703,-0.0908135503115419,0.0233072257448403,-0.136495712771429,-0.0451313878516548,9.82924170153727e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",33703,-0.0039699064755906,0.029888756531357,-0.0625518692770503,0.0546120563258691,0.894336286508767
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",33703,-0.0265497793938,0.00891738499924605,-0.0440278539923222,-0.00907170479527771,0.00291502123167535
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",35888,-0.0482760708872,0.00983182099508605,-0.0675464400375686,-0.0290057017368313,9.21853405802054e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",35888,0.0204250354213672,0.00795523594448103,0.00483277297018436,0.03601729787255,0.0102555743448516
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",35888,0.0203729086219567,0.00787181524443728,0.0049441507428596,0.0358016665010537,0.00966278715532273
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",35889,-0.0438595134581886,0.0191843817440162,-0.0814609016764603,-0.00625812523991685,0.0222593146674755
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",35889,-0.0318364471315656,0.0125385516364762,-0.0564120083390589,-0.00726088592407232,0.0111267720426173
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",35889,-0.00474087096942327,0.0156781120966174,-0.0354699706787935,0.0259882287399469,0.762361626481558
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52345,-0.0103700512794804,0.0183369129259271,-0.0463104006142976,0.0255702980553367,0.571718635416052
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52345,-0.0139091809770498,0.012041901686461,-0.0375113082825133,0.00969294632841369,0.248073437366657
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52345,-0.0885552246145953,0.036323887332111,-0.159750043785533,-0.0173604054436578,0.0147775591817849
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52345,-0.041585328579806,0.0136091977084238,-0.0682593560883167,-0.0149113010712954,0.00224759784606925
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52345,-0.0253236205901727,0.0148817440908645,-0.0544918390082671,0.00384459782792175,0.0888306413742396
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52345,-0.0580672026284912,0.016524820230717,-0.0904558502806965,-0.025678554976286,0.000442199498737667
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52345,0.0052699024876103,0.00532032639393228,-0.00515793724449698,0.0156977422197176,0.321927257968825
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,28153,-0.0317388100420155,0.0177937025817927,-0.0666144671023293,0.00313684701829818,0.0745413743019966
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,28153,0.00236073632207723,0.022643512741628,-0.0420205486515137,0.0467420212956681,0.916970564985387
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,28153,0.0258951615174813,0.0165697543742484,-0.00658155705604547,0.0583718800910081,0.118174070591903
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,28153,0.0087837514282435,0.0137572886392049,-0.0181805343045981,0.0357480371610851,0.523195432561497
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52482,-0.00408113993910329,0.00570356774815615,-0.0152601327254894,0.00709785284728277,0.474280287830338
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52482,-0.0285208502388584,0.0167404638749363,-0.0613321594337336,0.00429045895601677,0.088446641806727
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52482,0.00347366290366301,0.00575270033124131,-0.00780162974556996,0.014748955552896,0.545960317404508
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52482,-0.0071015072981244,0.00559389417856564,-0.018065539888113,0.00386252529186425,0.204269376166641
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52482,-0.0241361940499362,0.0081119512454466,-0.0400356184910116,-0.00823676960886091,0.0029286350233106
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52482,-0.000390712969024123,0.00832562818198996,-0.0167089442057245,0.0159275182676762,0.962570184037499
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52482,0.00664046099043421,0.00616353904916111,-0.00544007554592156,0.01872099752679,0.281320536484646
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52482,-0.0505315736245712,0.017515730901493,-0.0848624061914975,-0.016200741057645,0.00391798853195351
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43212,0.0239670831329937,0.00610951309058821,0.0119924374754408,0.0359417287905466,8.77871329437418e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43212,0.00624396123831156,0.00641878567345727,-0.00633685868166468,0.0188247811582878,0.330682952132438
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43212,-0.00969005940232021,0.00768570176726724,-0.024754034866164,0.00537391606152358,0.207399554978898
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43213,-0.000197696428925229,0.010553926227782,-0.020883391835378,0.0204879989775275,0.985055072146323
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43213,0.000106136282132975,0.00677814973094821,-0.0131790371905255,0.0133913097547915,0.987506923036868
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52239,0.00754648417724947,0.00631515697136585,-0.00483122348662759,0.0199241918411265,0.232104960504613
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52239,0.011333981355799,0.00495083211907166,0.00163035040241853,0.0210376123091795,0.022068750449455
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52239,-0.00109240807241051,0.0059105816214695,-0.0126771480504907,0.0104923319056697,0.853369633134246
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52239,0.035316913499286,0.00919285351037204,0.0172989206189568,0.0533349063796152,0.000122411356474711
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52255,0.00616726554219145,0.00543438268048332,-0.00448412451155586,0.0168186555959388,0.256443406280347
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52255,0.0574110784895948,0.00744707588634018,0.0428148097523681,0.0720073472268216,1.30726845472422e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52345,-0.00896221064685445,0.00573934357435312,-0.0202113240525866,0.00228690275887766,0.118407663693249
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52345,0.015909316013422,0.0070671896993763,0.0020576242026444,0.0297610078241995,0.0243835223010147
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52345,-0.0166567398062479,0.010575755891185,-0.0373852213529705,0.00407174174047471,0.115269202765067
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52345,-0.007564024524115,0.0123295266921792,-0.0317298968407862,0.0166018477925562,0.539558192578609
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52345,-0.0204703014086898,0.0122022729273538,-0.0443867563463033,0.0034461535289237,0.0934398924987753
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52345,-0.0247090176043384,0.0174043899203847,-0.0588216218482924,0.00940358663961557,0.155705893945638
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40089,0.000223271827038885,0.00345757619196904,-0.00655357750922043,0.0070001211632982,0.948513451702301
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X864.Number of days or week walked 10+ minutes,51953,0.0393595638191413,0.0263086605365555,-0.0122054108325074,0.09092453847079,0.134646986789167
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X874.Duration of walks,48268,0.00477033623922368,0.00258071100318796,-0.00028785732702471,0.00982852980547208,0.0645481828914819
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,51212,0.0680181854284377,0.0257012526712839,0.0176437301927213,0.118392640664154,0.0081377759733533
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X894.Duration of moderate activity,45025,0.0221396729258016,0.030899780530783,-0.0384238969145331,0.0827032427661363,0.473690969620972
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X90087.No-wear time bias adjusted average acceleration,30382,0.0147104576087967,0.00520707070095402,0.00450459903492683,0.0249163161826666,0.0047410515603354
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,51219,0.116481171396256,0.0263805943642261,0.0647752064423725,0.168187136350139,1.01204240867877e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X914.Duration of vigorous activity,40032,0.0109433267424485,0.00328987822779084,0.00449516541597844,0.0173914880689185,0.000881834849141295
